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ABSTRACT
Intestinal uptake and translocation of polystyrene microparticles across
epithelium have been studied in animals, but similar studies in human subjects
are scarce. Inorganic microparticles have been reported in the intestinal mucosa
of patients with inflammatory bowel disease, and inorganic microparticles
conjugated with lipopolysaccharide have been shown to stimulate IL-ip secretion
from lamina propria macrophages. Accordingly, it is possible that dietary non-
degradable microparticles are involved in the pathogenesis of IBD.
The aim of this thesis was to investigate the uptake of inert microparticles by
human intestinal mucosa in vitro and to consider a possible relationship with
disease pathogenicity. Another aim of this project was to investigate the extent of
microparticle-laden macrophages in mucosa affected by inflammatory bowel
disease.
A model to study uptake of inert microparticles across human colon mucosa has
been developed. Uptake of inert microparticles was examined by confocal and
electron microscopic studies in cultured human colon mucosa. Also, the effect of
lipopolysaccharide on the uptake of inert microparticles by inflamed colon
mucosa was studied. The survival of cultured biopsies was assessed by
bromodeoxyuridine labelling of crypt proliferating cells and the morphology of the
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tissues was assessed by light and electron microscopy. In resected human
intestine, inorganic microparticles were examined by X-ray microanalysis and
microparticle-laden cells were quantitated by image analysis in immunostained
cells.
In vitro labelling of cultured colon biopsies by bromodeoxyuridine was
comparable to in vivo bromodeoxyuridine labelled cells in mice.
Lipopolysaccharide had no effect on the morphology of human colon epithelium
as examined by light and electron microscopy. In uptake studies with organ
culture, the numbers of inert microparticles in inflamed intestinal mucosa were
greater than in normal intestine. The numbers of microparticles were increased
significantly in lipopolysaccharide-treated inflamed tissue. The increased
formation of macropinosomes indirectly in response to LPS may explain the
observed increased uptake of inert microparticles in IBD. An image analysis
technique was applied to quantify microparticle-laden macrophages and revealed
a significant increase in microparticle-laden macrophages in Crohn's disease. By
X-ray microanalysis, inorganic microparticles were confirmed as compounds of
titanium, silicon, aluminium and chromium. Detection of chromium in resected
human intestine has not been reported before. Chromium has been reported as
granulogenic in other tissues, but not in the intestine.
This study has shown for the first time that human colonic cells can take up
microparticles in vitro and that this uptake is enhanced in the presence of
17
inflammation. It is further enhanced in the presence of LPS. Microparticles of
aluminium, silicon, titanium and chromium may be found within the macrophages
in inflamed intestinal mucosa from IBD patients. Chromium is granulogenic in
certain tissues. The routes of uptake of microparticles are discussed in detail in
this thesis.
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CHAPTER 1: INTRODUCTION AND AIMS
Transepithelial transport of bacteria and viruses across intestinal epithelium has
been reported in both animal experiments and in cultured cell lines. Experiments
with animal tissues, both in vivo and in vitro, have demonstrated uptake and
translocation of microparticles across intestinal mucosa. However, the pathways
and mechanisms of uptake of microparticles are not totally clear. It was believed
that small microparticles may be transported through the epithelial cells of the
intestine but uptake and translocation of 2-p.m-sized microparticles across
intestinal epithelium have been demonstrated in animal experiments.
Microparticle uptake studies with colonic tissues are very few, and it is generally
thought that the colon is relatively impermeable to microparticles.
Most of the microparticle uptake studies have been conducted with a view to the
microencapsulated delivery of a drug or vaccine. It is widely believed that the
uptake of polystyrene microparticles occurs across the intestinal mucosa in
experimental animals. A corollary to the results of these experiments is whether
the intestinal uptake of non-degradable microparticles is harmful in man.
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There is no experimental evidence that non-degradable microparticles are taken
up by the human intestinal mucosa. Also, the effect of any luminal factors such
as lipopolysaccharide on this uptake is not available.
Non-degradable microparticles have been reported in inflamed human intestinal
mucosa. The possible benefit of a microparticle-free diet in Crohn's disease is
now being cautiously considered in the knowledge that environmental
microparticles ingested in our diet as food additives and in pharmaceutical
products as adjuvants may be related to the perpetuation of Crohn's disease.
Therefore in this thesis, the following research questions have been addressed:-
1. Does intestinal uptake of non-degradable microparticles occur in man?
2. Does any pre-existing pathology affect this uptake process, or do any luminal
factors such as lipopolysaccharide influence it?
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What is the extent of microparticle uptake by the gut in health and disease in
human?
What are the types of microparticles and extent of microparticle-laden cells in
the human intestine?
24
CHAPTER 2: REVIEW OF LITERATURE
Barrier function of the gastrointestinal tract and microparticle uptake
Background
The gastrointestinal tract is the largest organ in the human body exposed to
noxious agents present in the external environment (1), and a major function of
this organ is to protect the host from such noxious agents as microbes,
microparticles and macromolecules present in the gastrointestinal lumen. This is,
of course, secondary to the absorption of nutrients but it is an important function
of the gastrointestinal tract. It is achieved by the development of a barrier of
epithelium, i.e., cells joined together by tight junctions in the intestinal tract (2,3)
and by covering the apical surfaces of these intestinal cells with secretory IgA
antibodies and mucus to prevent the entry of harmful agents into the interior
milieu of the intestine (4,5).
It is widely accepted that secretory IgA provides a first line of defence against
bacterial invasion of mucosal surfaces. Secretory IgA consists of a secretory
component (SC) and immunoglobulin A (IgA). Secretory component is a
transmembrane polypeptide (MW ~ 80,000), preferentially expressed on the
basolateral aspect of the intestinal epithelial cells. It has five extracellular
domains, thus placing SC in the immunoglobulin super family (6). SC functions
as the cellular receptor of polymeric IgA and IgM secreted by lamina propria
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plasma cells. The J-chain on polymeric IgA or IgM probably binds to secretory
component. Following binding the receptor complex is internalised and
transported through the cells into the lumen (7). The process by which secretory
IgA prevents invasion of bacteria is not totally clear (8,9).
Mucus
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Figure 2. 1: Schematic diagram of intestinal barriers to the luminal contents
The intestinal mucus (also called glycocalyx) creates a diffusion barrier as well as
a highly degradative microenvironment within the gastrointestinal lumen (10,11).
Mucus secreted by goblet cells in the intestinal epithelium contains specific
receptors to bind endogenous enteric bacteria (12), and this binding prevents
potential pathogens from binding to (and colonising) the mucus layer (13). The
negative ionic charges of mucus glycoprotein and the ability of mucus to create a
hydrophobic luminal barrier enhance the protective ability of the gastrointestinal
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mucus (14). The degradative function of the glycocalyx is achieved by entrapping
pancreatic and hydrolytic enzymes that impede the access of macromolecules
and microorganisms to the apical cell membrane of the intestinal epithelial cells
(10).
Even with this highly developed barrier function in the gastrointestinal tract, there
is both clinical and experimental evidence that luminal contents traverse the
epithelium (15,16). Mechanisms of entry of microbial pathogens i.e., bacterial
translocation or passage of macromolecules such as antigens across the
intestinal mucosa have been well studied. However, studies related to the entry
of other luminal contents such as microparticles and nutritionally insignificant
intact protein (non-nutritive protein) in the human intestine are very few. Most of
the microparticle uptake studies in animals have been done with an aim to
observe encapsulated drug or vaccine delivery through the intestine. It is now
emerging that the entry of microparticles may be of significance in the process of
inflammation, e.g., in Crohn's disease (17, 18). Similarly, entry of intact proteins
across the intestinal mucosa may result in a completely new type of infection
such as the transmissible spongiform encephalopathies (TSEs) (19). Most
studies to assess the barrier function of the intestinal epithelium have been
conducted to investigate the translocation of bacteria and bacterial products.
Studies on the uptake of microparticles and TSE agents (prions) across the
human intestinal epithelium, with reference to pathogenesis, are almost non¬
existent. For example, entry of microparticles in this way may perpetuate
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inflammation and entry of prions may initiate variant Creutzfeldt-Jacob disease
(vCJD). A better understanding of the limitations of the protective functions of the
gastrointestinal tract which has a surface area of approximately 200-300 m2
should enable us to improve defences against exogenous noxious agents, and
should also help to develop further preventive and therapeutic applications.
In the following chapters, maintenance of the barrier function of the
gastrointestinal tract will be considered with special reference to the ways in
which environmental agents and possibly prions may challenge the defence
mechanisms of the human gut.
Structure of the gastrointestinal tract
The gastrointestinal tract extends from the mouth to the anus and its basic
tubular structure varies with its appendices and evolutionary modifications in
different species. Research work in this thesis will focus only on the large and
small intestine, and discussion therefore, in this thesis will be limited to these
parts of the intestine. Although animal models must be considered the principal
interest will be the human gut. The gastrointestinal mucosa is the interface
between nutrients and extraneous substances and the internal milieu and
therefore plays a crucial role in protecting the host from harmful substances (20).
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Organisation of the gastrointestinal mucosa
The gastrointestinal mucosa consists of (1) epithelium; (2) lamina propria of
loose connective tissue; and (3) the muscularis mucosa. The intestinal epithelium
consists of columnar cells, ~ 20 pm high x 8-10 pm wide, each with an oval
nucleus in the basal half of the cell. Columnar epithelial cells are interspersed
with mucus-secreting goblet cells and intraepithelial lymphocytes. The epithelial
cells are held together by junctional complexes (tight junctions) that prevent
passage of unwanted substances via the intercellular spaces. Beneath the
junctional complex lies the gap junction that allows small molecules and ions to
diffuse between adjacent cells. In the small intestine mucosa there are finger- like
projections (villi) that again have microscopic projections (microvilli). The purpose
of these two special developmental adaptations is to increase the surface area
for absorption. The large intestine is devoid of villi.
Other than epithelial cells, a special type of cell called microfold or 'M' cell
overlies the lymphoid follicles in the intestine. Lymphoid follicles are organised
lymphoid tissues in the gut or "gut associated lymphoid tissues"(GALT).
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Organised lymphoid tissues of the gastrointestinal tract
Organised lymphoid tissues are situated from the proximal intestine to the rectum
(21,22). The basic difference between organised lymphoid tissues in the gut
(GALT) and secondary lymphoid structures such as spleen, is the absence of a
capsule and lack of a draining system as afferent and efferent lymphatics. Also,
the epithelial lining of the GALT is different from that of the secondary lymphoid
tissues both functionally and structurally.
In the small intestine, lymphoid tissues are in aggregated forms called Peyer's
patches, whereas in the appendix and colon they are called lymphoid follicles.
Peyer's patches of the small intestine
In 1667 De Peyer first described the organised lymphoid tissue of the small
intestine. These organised areas of lymphoid tissue in the mucosa appear as
small round blebs on the mucosa.
The numbers of Peyer's patches in the small intestine vary according to age,
highest in adolescence (~ 250) and lower at the extremes of age (~ 100) (23). It
is unknown why there is an increase in the number of mucosal lymphoid tissues
from birth followed by a decline in old age. However, the general view is that the
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presence of luminal antigen stimulates the increase in the number of mucosal
lymphoid tissues (24,25). The number of Peyer's patches increases from the
duodenum to the terminal ileum in mammalian intestine.
Other than Peyer's patches, solitary lymphoid nodules and lymphocyte-filled villi
have been reported in human small intestine (26,27). However, the functional
significance and structural details of these structures has not been as well
studied as Peyer's patches.
Lymphoid follicles of the colon
In 1926, organised lymphoid tissues (lymphoid follicles) in human colon were first
described by Dukes and Bussey (21). Small, white nodules 1 to 4 mm in size are
studded in the colonic mucosa. There are two types of lymphoid follicles: non-
dome or flat type and dome type; the proportion of these two types of lymphoid
follicles in the colon is 10:42 (26). In flat type follicles 'M' cells have not been
reported in the follicle-associated epithelium. As with Peyer's patches, the
average numbers of follicles per cm2 in old age decrease to 3 from 8 in
childhood. Anatomically, lymphoid follicles are distributed all over the colon, but
the number gradually increases from the caecum distally to the rectum (21,28).
Similar structures have been reported as lymphoglandular complexes in animals
(29).
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Differences between lymphoid follicles of the colon and Peyer's patches in
the small intestine
The lymphoid follicles in Peyer's patches of the small intestine occur in
aggregated forms whereas follicles in the colon appear in isolation. Also,
lymphoid follicles in Peyer's patches lie above the muscularis mucosa, but the
lymphoid follicles of the colon may appear below the muscularis mucosa or
disrupt the muscularis mucosa and become very superficial close to the lumen.
Follicle associated epithelium (FAE)
In general, structurally organised lymphoid tissues in the human gut consist of a
follicle or germinal centre. The follicle centre is surrounded by a zone of small
lymphocytes known as the mantle zone. The mantle zone merges into a mixed
cell zone. Towards the luminal side the mixed cell zone forms a dome like
structure and is covered by a specialised epithelium (follicle associated
epithelium, FAE) in both forms of organised lymphoid tissue.
Follicle-associated epithelium is cuboidal in shape and contains fewer goblet
cells but has specialised types of microfold cells or 'M' cells described by Owen
RL et al. (30). Morphological features such as poorly organised brush border,
deficient apical glycocalyx and alkaline phosphatase, expression of Sialyl Lewis
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A antigen and presence of lymphocytes within the pockets of these cells are
most often used to differentiate 'M' cells from absorptive enterocytes [Figure 2.2],
although the absolute specificity of these is debated. Functionally these cells are
believed to be specialised to sample antigens from the gut lumen. However, the
developmental origin of these cells is yet unknown (31).
Figure 2. 2: Schematic diagram of follicle associated epithelium showing M cell
with lymphocytes in its pocket
There are basically two schools of thought on the development of 'M' cells: [a]
studies indicate that M cells are developed through a completely separate
process of differentiation from crypt cells (32); [b] alternatively, 'M' cells are
derived from the phenotypic conversion of mature intestinal epithelial cells with
induction from the surrounding lymphocytes (33). After extensive research over
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the last three decades since their description in 1974 there is disagreement on
the criteria for identification of M cells. In a recently published elaborate study on
'M' cells, Onori and his colleagues concluded, "the concept that distinct cell
types (enterocytes and M cells) can be identified in the rat dome epithelium does
not appear to be valid". Similarly, other researchers have questioned whether 'M'
cells are a separate entity or a dynamic morphofunctional shape of normal
intestinal epithelial cell (34-36). There are differences in the organisation of gut-
associated lymphoid tissues between animals and man (37) and this makes it
difficult to relate work with experimental animals directly to human models.
Microfold or 'M' cells
Less than 1% of mucosal epithelial cells are M cell (38). These are deficient in
cytoplasmic acid phosphatase and microvillus-associated alkaline phosphatase
(39) and are probably HLA-DR-ve (40). It is unlikely, therefore, that these play a
role in antigen presentation, but are more likely a portal for entry of luminal
contents into the dome area of the follicle. This has been clearly demonstrated by
entry of reovirus and horseradish peroxidase, which adhere and are transported
through 'M' cells in mice (41,42). Similarly, uptake of poliovirus by humans was
demonstrated by Scinski et al, [1990] (43). It has been postulated that soluble
proteins, microparticles, and live microorganisms may traverse through the M
cells by transcytosis and are delivered to the basolateral side of the cell packed
with T and B lymphocytes. It has also been demonstrated that HLA-DR+
epithelial cells of the dome epithelium have a capacity to process and present
antigen (44).
Beneath the epithelium, the lamina propria consists of loose connective tissue
containing immune cells such as plasma cells, macrophages, and lymphocytes.
Absorptive functions of the gastrointestinal tract
The major functions of the gastrointestinal tract include the secretion of fluids and
digestive juices; absorption of nutrients; mixing and propulsion of foods and
digestive secretions; and the neurohumoral co-ordination of these processes.
The small intestinal epithelium absorbs nutrients. A significant amount of
research has been done to elucidate the mechanisms of absorption and different
pathways by which a variety of dietary nutrients are absorbed every day in
mammals. In brief, carbohydrate, protein and fat in the intestinal lumen are
degraded from polymers to simpler forms by gut secretions and processing, prior
to their absorption. Nutrient molecules enter the enterocytes at the apical cell
membrane and exit at the basolateral side. The first step in this process is the
attachment of a nutrient molecule to its receptors in the apical cell domain.
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Macromolecules with the capacity to evoke an immune response can also cross
the intestinal epithelial cells and this is a physiological phenomenon. From
published work, it is now clear that there are two major pathways by which
macromolecules can cross the epithelium. They can bind to receptors and shuttle
through the absorptive cells or they can pass through specialised 'M' cells. A third
possibility is that antigenic fragments may cross the epithelial cells for
presentation by class II MHC molecules at the basolateral membrane. Antigenic
fragments could be generated during epithelial transport or could be processed
from whole macromolecules that have traversed the epithelium. The definitive
evidence for this mode of transport is yet to be confirmed.
Since the description of M cells by Owen et al. [1974], other than
macromolecules, 'M' cells in the Peyer's patches have been widely accepted as a
route for the entry of microparticles, bacteria and viruses (38). However,
transport of microparticles and bacteria through intestinal epithelial cells
(transcellular transport) has not been ruled out. In animal studies it has been
demonstrated that microparticles can traverse through the epithelial cells (45)
and bacteria have developed strategies to traverse through the intestinal
epithelial cells other than by passing through the 'M' cells (46-48).
It therefore appears that a mechanism to exclude harmful gut luminal contents
that can cross the barrier of the gastrointestinal mucosa is as important as
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absorption of nutrients to protect the host from the damaging effects of the
noxious agents.
So far, little attention has been paid to this important aspect of intestinal function.
If this exclusion mechanism is not absolutely efficient, it is important to determine
and define substances that can get through the epithelial barrier of the host and
to identify any consequence of such entry. As mentioned earlier, of the three
major noxious agents in the gastrointestinal lumen, entry of bacteria and their
products including antigens has been well studied but entry of microparticles
from the potentially pathological point of view has been virtually ignored. The
pathological role (if any) of ingested microparticles and their subsequent location
in the intestine requires further study.
In the following sections, microparticles and their routes of entry across the
gastrointestinal mucosa will be considered. In the published literature,
microscopic particles have been described as particulates, ultrafine particles and
microparticles. There is no general consensus in terminology. In this thesis, the
term microparticles will be used for all of these.
Entry of non-nutritive proteins across the gastrointestinal mucosa
Although highly efficient hydrolytic systems exist in the gastrointestinal mucosa
that form a chemical barrier, studies have shown that in the physiological state a
fraction of intact macromolecules (e.g., proteins) bypasses the gastrointestinal
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barrier and these are absorbed through the gastrointestinal tract (49,50). This
finding is established particularly in neonate and young animals as well as in
young human infants. Studies have also demonstrated absorption and transport
of intact macromolecules in adult mammals, although to a lesser extent. It is well
established that penetration of epithelial barriers by the antigens is the first step
in the development of protective mucosal and systemic immune responses (24),
but the significance of the transport of intact macromolecules across the
intestinal epithelium in adults is not fully understood (51).
Gastrointestinal uptake of microparticles
The wall of the mammalian gastrointestinal tract was for long assumed to be an
impermeable barrier to the passage of microparticles (52,53). However, the
passage of large non-dissolved food microparticles from the intestinal lumen into
the circulation was reported as early as 1844 by Herbst (54). At the beginning of
the twentieth century, intact starch microparticles in blood and urine were
observed after per oral administration by Hirsh R [1906], and by Verzar F
[1911 ](54). In the early 1960's, Payne et al. (55), and others have demonstrated
the intestinal uptake of microparticles in animals (56).
The transmucosal transport of microparticles in the gastrointestinal tract was
most extensively studied by Volkheimer (57). He demonstrated microparticles of
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corn (3-10 vim), potato (5-10pm), rice (3-10pm), pollen (10-12 pm), diatoms (5-12
pm) and cellulose in the blood and urine after peroral administration.
A significant number of studies were conducted to demonstrate uptake and
translocation of microparticles by the gastrointestinal mucosa and to understand
the mechanisms of this process (Table 2.1).
Table 2.1 1: Summary of studies investigating uptake and translocation of inert,
non-motile microparticles by the intestinal epithelium.
Species Route of Microparticles Site of particle Reference
Studied inoculation location
Rat Oral Starch Epithelial cells 58
Human Oral Starch Venous blood 54
Human Oral Mineral Urine 59
< 10 pm
Mouse Oral Carbon Macrophage in PP*; 60
(20-50 nm) Lamina propria
Chicken Oral or Carbon Bursal epithelial cells; 61
Intracloacal Macrophages
Hamster Ileal loops Ferritin Epithelial cells, 62
(50-60 A) macrophages
Chicken Bursa Ferritin, india ink Epithelial cells 63
Rabbit Appendix
Mouse Ileal loop
Chicken Intracloacal Latex micro¬ Bursal epithelium; 61
particles (1 pm) Macrophages
Mouse Oral Latex micro¬ Macrophages; Dome 64
particles (2 pm) of Peyer's patches
Mouse Oral Latex micro¬ Mesenteric lymph 65
particles (1 pm) nodes; Phagocytes
*PP = Peyer's patch;
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Three possible routes of entry of microparticles across the gastrointestinal
epithelium have been suggested: (1) uptake by a paracellular pathway; (2)
uptake by the M-cells in the Peyer's patches; and (3) transcellular uptake i.e.,
transport via the epithelial cells lining the intestinal mucosa.
1. Uptake by a paracellular pathway
Volkheimer (57) and Alper et al. (66) have detected a significant quantity of
microparticles in the blood 10 minutes after peroral administration in
experimental animals. This seems to be extremely rapid and can only be
explained by a paracellular pathway.
It has been reported that paracellular passage of microparticles between the
enterocytes was the major mechanism of intestinal uptake of larger (> 1pm)
particles. Scanning electron microscopic studies had revealed a loosening of the
tight junctions of the intestinal mucosa in the immediate neighbourhood of the
goblet cells enabling the passage of the microparticles.
Microparticles in the nanometre range have been reported in the intercellular
spaces by Aprahamian et al. (67). Microparticles of ferritin and virus
microparticles were reported in the intercellular spaces of absorptive cells in rats
and this was attributed to the disruption of junctional complexes as a result of a
protein-deficient diet (68).
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In a number of animal studies, macromolecular tracers were not observed in the
paracellular spaces surrounding undamaged epithelial or goblet cells (69).
Therefore when the normal barrier of epithelial tight junction is considered, the
passage of microparticles (>1pm) between absorptive cells (paracellular route)
seems rather less likely than passage through the cells (intracellular or via 'M'
cells). In normal circumstances, the zona occludens (or tight junctions) between
the epithelial cells is thought to act as an effective barrier against the absorption
of all but the smallest molecules. However, in vitro studies it has been
demonstrated that if this barrier is damaged by various treatments e.g., aspirin
(70), alcohol (71,72) and hypertonic solutions, there is an enhanced uptake of
macromolecules (73).
Aprahamian et al. (67) also observed microparticles (< 1pm, nanoparticles) in
defects of the mucosa between 10 and 15 min after intraluminal injection into the
intestine of Beagle dogs and described this phenomenon as 'persorption'.
2. Uptake via the M-cells
LeFevre et al. (64) clearly demonstrated involvement of Peyer's patches in the
uptake of 2 pm latex microparticles in mice. Their results indicated accumulation
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of latex microparticles in Peyer's patches during chronic feeding of microparticle
suspensions to mice.
Peyer's patches are located in the antemesenteric wall of the small bowel and
similar structures are also found in the colon as lymphoid follicles. Follicle-
associated epithelium (FAE) overlying Peyer's patches contains 'M' cells. FAE
contains a decreased number of goblet cells and the resulting decrease in mucus
secretion has been assumed to make the M-cell's surface environment more
accessible to microparticles or bacteria (74).
Membranous epithelial cells (M-cells) are believed to be specialised epithelial
cells overlying lymphoid follicles of the gastrointestinal and respiratory tracts (75).
These cells transport antigens from the lumen to the extracellular space, allowing
subsequent access to lymphocytes, macrophages, and plasma cells. In suckling
and adult animals they have been shown to be involved in the transport of
macromolecules (50).
Jani et at. (52) have observed uptake of fluorescent polystyrol nanoparticles of
sizes between 100 nm and 1 pm in the Peyer's patches after administration by
gavage to mice for 10 days. The particles were not distributed randomly in the
tissues, but were concentrated at the serosal side of the Peyer's patches.
Histologic investigations have revealed a translocation of the microparticles of 1
pm in size and smaller from the Peyer's patches to the mesenteric lymph nodes.
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The microparticles were easily visualised in ducts connecting the patches and
lymph nodes. A comparison between 125l-labelled 100 nm and 1 pm
microparticles demonstrated a higher uptake of the smaller microparticles.
Especially the smaller particles were also observed in the liver and spleen.
Studies involving polylactide, polyhydroxybutyric acid, polymethyl methacrylate,
ethylcellulose, cellulose acetate hydrogen-phthalate, cellulose triacetate, and
polystyrene microparticles (76) have shown that microparticles of diameter 1-10
pm are taken up by the Peyer's patches, whereas microparticles larger than 10
pm are excluded. Microparticles of a size below 5 pm traverse the Peyer's
patches, enter the mesenteric lymph nodes, and eventually enter the circulation
via the thoracic duct. Microparticles of a size between 5 and 10 pm do not
migrate out of the Peyer's' patches and can stay there for months.
3. Transcellular uptake (i.e., transport through the epithelial cells)
It is generally considered that small macromolecular complexes in the luminal
contents, e.g., microparticles and bacteria, may traverse the gastrointestinal
epithelium, but the exact mode for their transport varies with the structure of the
intruding substances.
Polystyrene microparticles of a size of 220 nm were observed within jejunal
epithelial cells 1 h after intragastric administration in the rat (56). The
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microparticles were occasionally observed between the microvilli or in the
terminal web. However, they were very numerous in the cytoplasm of the
epithelial cells, where they were enclosed in vesicles indicative of transcellular
uptake. At 2-4 h after their administration, the particles were observed in the
interstices of the lamina propria and in the lymphatics of the mucosa.
The observation of microparticle uptake by cells lining the intestinal mucosa has
been supported by electron-microscopic autoradiographic investigations (77).
Kreuter et al. [1989] observed radioactivity in the interior of epithelial as well as of
goblet cells between 90 min and 6 days after peroral administration of
polyhexylcyanoacrylate microparticles labelled with 14C. Earlier studies indicated
that smaller microparticles could be transported through the mucosal epithelial
cells. In 1995, Hodges et al. confirmed uptake and translocation of 2 pm
fluorescent polystyrene microparticles in rat enterocytes (48). They have clearly
demonstrated microparticles within the enterocytes and goblet cells of the
epithelial layer, in the lamina propria, and within crypt epithelium. In a number of
studies this group have demonstrated uptake and translocation of polystyrene
microparticles >1 pm within the epithelial cells of the animal intestine (48).
Similarly, Cartwright-Shamon J et al. have demonstrated 5 pm size yeast
microparticles within the apical enterocytes in mice and recommended that
microparticles move through the mucosal epithelial cells (45). It is now emerging
that M cells are not the only cells involved in uptake and transport of
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microparticles or bacteria; intestinal epithelial cells also take up and transport
microparticles and bacteria transcellularly (46,78).
However no study has yet demonstrated uptake and transport of polystyrene
microparticles in human intestinal mucosa.
In summary, evidence exists for the transport of microparticles in the nano- to
micrometre range by all three described routes. In a number of studies
(52,56,67,79,79) the simultaneous occurrence of more than one pathway has
been reported. It is possible that the major uptake pathway may vary in different
parts of the intestine.
The surface properties of microparticles may have an influence on the uptake
mechanism. However, in some studies there were no differences in uptake of
different materials (52,80). It is also possible that the gastrointestinal mucosa in
different species handles microparticles with different physicochemical surface
properties differently.
Regarding size of the microparticles, it appears that the uptake of smaller
microparticles is significantly greater than that of larger microparticles
(52,55,57,76,81). Also, smaller microparticles often accumulate in clusters after
uptake (56,64,67,77,82).
45
Cellular pathways of microparticle uptake
The cellular pathway by which microparticles are translocated is not totally clear.
Sanders et al. [1961] observed polystyrene microparticles (220 nm) within the
cytoplasm of the jejunal epithelial cells in rats, where they were enclosed in
vesicles (56). This finding was supported by electron microscopic investigation
(77). The presence of microparticles enclosed in vesicles within the cytoplasm of
the cells suggests an endocytic uptake mechanism. This mode of uptake and
transport was suggested as a second pathway for translocation of luminal
microparticles (52).
Endocytosis
Endocytosis refers to the process by which cells take up macromolecules,
microparticles and even other cells in special cases without passing through the
membrane (83,84). Endocytosis is an active process that requires metabolic
energy. The term encompasses both pinocytosis and phagocytosis.
Phagocytosis occurs in specialised cells e.g., macrophages.
Of all of the endocytic mechanisms, receptor-mediated endocytosis has been
most extensively studied.
46
Four morphologically distinct endocytic pathways have been characterised and
are illustrated in Figure 2.3. They differ in the composition of the coat (if any) and
in the size of the detached vesicle.
1. Receptor-mediated endocytosis
invaginations of the cytoplasmic membranes and small transport vesicles
decorated by an electron-dense 'bristle' coat were first detected in insect oocytes
by conventional electron microscopy. Yolk proteins were clearly concentrated
within these 'coated' pits and vesicles, leading to the conclusion that they were
the vehicles of receptor-mediated endocytosis (85). Isolation of the coated
vesicles led to identification of the coat constituents as clathrin, which forms a
polygonal lattice on the surface of the membrane, and adaptor (or assembly)
protein (AP) complexes, which mediate the assembly of the clathrin lattice on the
membrane (86). Macromolecules to be taken up are recognised and bound by
the specific membrane receptors in the coated pits. The binding often leads to
aggregation of receptor -ligand complexes, and the aggregation triggers




The discovery of non-coated invaginations of the plasma membrane, 50-80 nm in
diameter (Figure 2.3b) preceeded the discovery of coated pits. Caveolae are
highly abundant in epithelial cells and it has been suggested that these vesicles









Figure 2. 3: Multiple endocytic pathways in mammalian cells (a)
clathrindependent pinocytosis (b) caveolae (c) non-coated vesicle
(d) macropinocytosis.
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However, failure to detect detached vesicles unambiguously derived from the
plasma membrane invaginations or to identify ligands transported by them had
led to uncertainty as to whether caveolae mediate classical endocytic events
(87,88). Quick-freeze images of caveolae revealed a granular, spiralling coat
structure not detectable by conventional electron microscopy (89). It has been
proposed that caveolin/VIP21, a 21kDa integral phosphoprotein can
immunolocalize caveolae and is a major structural constituent of this coat. In a
recent study, however, treatment of cells with cholesterol oxidase caused the
quantitative redistribution of caveolin to the Golgi complex without the
appearance of caveolae at the cell surface (90). A structural role for caveolin
remains to be firmly established.
3. Non-coated vesicles
It is apparent that not all 'non-coated' invaginations observed on the plasma
membrane by conventional microscopy are caveolae (88). Non-coated
invaginations that pinch off from smooth vesicle carrying the fluid-phase marker
horseradish peroxidase (HRP) into cells have been extensively characterised in a
number of cell types (91,92). These non-coated vesicles are on average larger
than individual caveolae and slightly smaller than coated vesicles (Figure 2.3c).
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The presence or absence of the caveolar marker caveolin will help to distinguish
unambiguously these two classes of non-coated vesicles.
4. Macropinocytosis
Macropinosomes are non-clathrin-coated vesicles, mostly between 0.5-2.5 pm in
diameter, formed preferentially at the leading edge of the cell and upregulated in
response to growth factors and phorbol esters (93). It has been reported that a
significant number of macropinosomes are several microns in diameter (94). The
formation of macropinosomes is accompanied by, but not necessarily dependent
on, membrane ruffling (Figure 2.3d). Whether their formation occurs constitutively
or transiently is not totally clear. The uptake of polystyrene microparticles has
been suggested as a process of macropinocytosis and in a recent published
study it has been proposed that macropinocytosis and phagocytosis are
functionally identical processes (95).
The uptake of microparticles across the gastrointestinal tract mucosa is an
important phenomenon that may have pathological and immunological
implications. We ingest thousands of microparticles as part of our diet or as a
result of environmental contamination. The potential problems that can occur as
a result of uptake of a small percentage of these ingested microparticles are not
known. The presence of non-degradable microparticles e.g., titanium in the
intestinal milieu has attracted scientific interest and debate about a possible
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relationship between ingested inorganic microparticles and perpetuation of
inflammation in inflammatory bowel disease (17,96).
Gut luminal bacteria and lipopolysaccharide
The human intestine contains a complex and dynamic microbial ecosystem and
at any given time, a specific region of the large intestine may contain > 400
bacterial species (97). Various bacterial products may be harmful to the host and
bacterial endotoxin has attracted much attention by the scientific community for
its role in the intestine. Bacterial endotoxins are distinguishable from exotoxins by
the following characteristics: (i) endotoxins are an integral part of the outer layer
of the bacterial cell wall; (ii) they are heat stable; (iii) they are toxic but much less
potent and less specific in their cytotoxic effect than bacterial exotoxin; (iv) they
are not convertible to toxoids; and (v) they are not rendered non-toxic when
combined with homologous antibody.
Pfeiffer [1892] first suggested that part of the bacterial structure could be harmful
to the host when released by disintegration of the cell and he called it endotoxin
(98). It was subsequently evident that endotoxins can be released from intact
bacteria without noticeable structural damage to the cell membrane. Chemically,
endotoxins consist of lipopolysaccharides (LPS) which are long-chain phosphate
containing heteropolymers with three distinct regions [Figure 2.4],
Figure 2. 4: Schematic diagram of a gram-negative bacterial cell wall. Region I -
O- specific units of oligosaccharides. Region II - core structure
common to a single genus. Region III - lipid component closely
associated with the cell bound protein.
Region 1 consists of repeating units of oligosaccharides; particular sugar units,
especially the terminal ones, confer immunological specificity on the respective
O-antigens.
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Region 2 is the core structure that is specific to a gram-negative bacterium but
varies among different genera.
Region 3 is the component that links the lipopolysaccharide macromolecule to
cell-bound lipoprotein. The endotoxic properties of the lipopolysaccharide are
associated with this region which consists of two components: A and B. These
lipid components are separable and lipid B can be easily detached and is
biologically inactive. Lipid component A consists of chains of glucosamine
disaccharide units connected by pyrophosphate bridges attached to a number of
long-chains fatty acids. (3-hydroxymyristic acid (a C14 fatty acid) is always present
and is unique to this lipid structure. There is variation in the other fatty acid
constituents in different bacterial species.
The lipopolysaccharide macromolecule can be broken down by phenol extraction
that separates the lipopolysaccharide moiety from the protein and most of the
phospholipid fraction.
Macrophages in the human intestinal wall
The gastrointestinal tract contains the highest number of resident macrophages
compared to any other organ in the human body (99). These macrophages are
predominantly located beneath the epithelial layer within the lamina propria in the
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human intestine. Human intestinal macrophages express a range of markers
including CD68 (100-102). Granules present within the lamina propria
macrophages express epithelial cell-associated antigens such as cytokeratin and
carcinoembryonic antigen; this suggests that they may play a role in the removal
of apoptotic epithelial cells and mucosal epithelial renewal.
Regarding the developmental origin of these phagocytic cells, it is now
established that tissue macrophages are haemopoietic in origin i.e., they are
derived from pluripotent stem cell precursors formed in the bone marrow. Under
the influence of growth factors, pluripotent stem cells divide and differentiate into
committed progenitor cells, which then further differentiate along restricted cell
lines [Figure 2.5]. The monoblast is the first cell that may be recognised as a
monocyte precursor because of its non-specific esterase content and the
presence of lysoszyme. These cells have IgG receptors and the capacity to
phagocytose. The monoblast develops into the promonocyte, which is the direct
precursor of the monocyte. Newly formed monocytes remain within the bone
marrow for a brief period (~24h) before entering into the circulation. In the













Figure 2. 5: Origin and differentiation of macrophages at different tissue levels
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When monocytes migrate into the tissues, they differentiate into resident
macrophages and may be within the tissues for days or months. The process
involved from differentiation to maturation and becoming "resident macrophages"
is not totally clear. Once within the tissue, the exact turnover time of tissue
macrophages is also unknown; it probably depends on the location of the tissues,
the microenvironment, and local inflammation or inflammatory process. Under
the influence of cytokines or lipopolysaccharides, localised macrophages may be
activated or stimulated so that they are morphologically, functionally and
metabolically changed to their resident state. The morphological change probably
increases the capacity to enter tissues, phagocytose and produce cytokines
including TNF a, IL-1, IL-6, and IL-8.
The half-life of peritoneal macrophages has been estimated to be approximately
2 weeks. Macrophages may persist in non-inflamed skin for many months, but
the ultimate fate of resident and activated macrophages is totally unknown. It has
been observed that after scavenging or phagocytosis, macrophages do not die
locally; instead they migrate from tissues to regional lymph nodes in an irregular
fashion (103). The fate of macrophages when they have reached the regional
lymph nodes is also uncertain.
In the lamina propria of the large and small intestine macrophages are able to
present antigens (44).
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Fox et al (1989) have detected viral RNA in macrophages in the lamina propria
but not in the epithelial cells in human rectum (104). Subsequently Fiocchi et al.
[1990] infected isolated human mononuclear cells with HIV in vitro but failed to
infect epithelial cells (105). It seems logical to accept that entry of any luminal
agent into intestinal epithelial cells, which are constantly shedding, may not
produce a significant impact on the mucosal pathogenesis of any disease. On the
other hand, luminal bacteria may persist in the macrophages of the human
intestine for unknown periods. Similarly, fluorescent microparticles (>1 pm) that
were detected in macrophages 7 days after peroral administration indicate
retention properties of these phagocytes (65).
Gastrointestinal mucosa and cytokines
Intestinal epithelial cells are in constant equilibrium between proliferation and
loss under physiological conditions. Stem cells in the basal crypt possess a high
mitotic capacity and their daughter cells differentiate into mature cell types such
as enterocytes, goblet or M cells over lymphoid follicles along the crypt-villus
axis. Once at the villus tip, these highly differentiated post-mitotic cells die via
apoptosis and are extruded into the lumen (106-108). Thus, maintenance of the
physiological function of intestinal cells depends on a delicate balance with
appropriate proliferation as well as loss. The physiological factors that regulate
crypt cell proliferation, differentiation and finally apoptosis are unknown.
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However, it is widely believed that a variety of growth factors, cytokines,
hormones, luminal nutrients and mesenchymal structures are involved in this
regulatory process. It has been demonstrated in vitro that immature crypt cell
proliferation is stimulated by factors such as TGF-a (109-111) and TNF-a (112),
whereas TGF-p (113,114) and IFN- y (115,116) inhibit mitotic activity.
o o
o o
Figure 2. 6: A schematic model of immunopathogenesis of mucosal
inflammation and involvement of cytokines. ° = antigen; M0 =
macrophage;TC = T cell; IFN = interferon; IL= interleukin; KGF =
keratinocyte growth factor; MMP = matrix metalloproteinase.
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Studies have shown that intestinal epithelial cells produce and secrete several
cytokines such as IL-6, IL-8, TNF-y and TGF- (3 indicating the potential for
autocrine and paracrine responses (117,118). In a variety of immune-mediated
pathological conditions such as Crohn's disease and ulcerative colitis there is a
dysregulation in the production of cytokines and this is believed to induce
morphological changes in the intestinal mucosa and functional derangement
(119,120). It is established that in the inflamed intestine of Crohn's disease and
ulcerative colitis there is an increase in the number of inflammatory cells. It is
also now becoming increasingly evident that because of increased epithelial cell
turnover and a high rate of apoptosis, cytokines released locally by infiltrating
inflammatory cells are playing a significant role in the pathogenesis of
inflammation in IBD [Figure 2.6],
Factors that could trigger the release of cytokines in the intestinal mucosa are
unknown. The human gastrointestinal tract is host to many millions of microbes
including many hundreds of bacterial species and it also contains microparticles
that might be involved in the liberation of proinflammatory cytokines (121).
From a substantial number of studies it appears that among the inflammatory
cells the number of macrophages are increased in Crohn's disease (122-126). It
has been suggested that bacterial endotoxin may activate macrophages and
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other reticuloendothelial cells to elaborate proinflammatory cytokines, which, in
turn, mediate the host responses (127).
Mucosal inflammation and microparticles
Background
The earliest histological features of mucosal inflammation are hyperaemia,
oedema, and infiltration of inflammatory cells such as polymorphonuclear cells
(PMNs), macrophages, and lymphocytes. These common pathologic
manifestations in inflammatory bowel diseases (IBD) are accompanied by an
imbalance in mucosal cytokine homeostasis. There is an up-regulation of
proinflammatory cytokines and down regulation of antiinflammatory cytokines.
Mucosal cytokines are in a delicate balance to maintain the epithelial cell
homeostasis. The triggering factor that imbalances pro- and antiinflammatory
cytokines in the intestinal mucosa is not totally clear. However, it is widely
believed that this imbalance in cytokine homeostasis is probably a secondary
event in mucosal inflammation.
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Inflammatory bowel disease
Inflammatory bowel disease is a chronic relapsing and remitting inflammation of
the intestinal tract. Although there has been progress in defining the
pathogenesis of these diseases, until now the aetiology of IBD remains obscure
(128).
Crohn's disease was first documented by Morgagni in 1761 and was followed by
reports early in the 19th century by Combe and Saunders. In 1913, a Scottish
surgeon Dalziel described a number of cases. Crohn, Ginzburgh and
Oppenheimer from Mount Sinai Hospital in New York in their classic paper
emphasised this inflammatory disorder as a distinct clinical and pathologic entity
(18). Similarly, ulcerative colitis was recognised as an entity distinct from bacillary
dysentery by Samuel Wilks of London in 1859 (129).
Crohn's disease and ulcerative colitis have similarities and some differences in
their presentation. Some features of these two diseases are so similar that in ~
10% of cases it is difficult to distinguish them and to make a diagnosis (130).
These similarities raise the possibility of a different expression of one disease.
Epidemiological studies to identify risk factors relating to IBD have observed an
association with early age, sex, smoking, ethnic population and geographical
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location, social class, life style, food and dietary habits. It is clear that
environmental and genetic factors are involved in developing IBD.
In this section I shall focus on the environmental and genetic factors that have
attracted most attention.
Environmental factors and IBD
Mycobacteria, measles virus and Crohn's disease
Crohn's disease can involve any part of the gastrointestinal tract but most
commonly involves the terminal ileum. Considering granuloma as a
pathognomonic feature for Crohn's disease, a bacterial aetiology was considered
most probable in the pathogenesis of Crohn's disease. Caseating granuloma is a
typical feature of tuberculous infection, but the typically non-caseating granuloma
of Crohn's disease raised the possibility of an atypical form of tuberculous
infection produced perhaps by Mycobacterium paratuberculosis(131-134). The
recovery of an unclassified acid-fast microorganism related to M.
paratuberculosis from Crohn's tissue was an exciting finding (131,135). Neonatal
goats fed such an organism developed granulomatous inflammation in the
terminal ileum and there was evidence of both cellular and humoral immunity
against the microorganism (136). However, subsequent results of similar
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experiments were inconsistent. Also, there was insignificant elevation of antibody
titres to mycobacterial antigens (132,133). Similarly, equivocal results of anti-
tubercular therapy in controls made it difficult to accept beyond doubt the role of
Mycobacterium species in the aetiology of Crohn's disease (137). In addition, the
results of sophisticated technology such as the polymerase chain reaction (PCR)
have been inconsistent in detecting mycobacterial DNA in intestinal tissue
affected by Crohn's disease (134,138,139). However, the homology between an
immunodominant mycobacterial antigen and human heat-shock protein (HSP60)
present in Crohn's disease tissue warrants further scientific work (140).
Similarly, the possible aetiological role of infection by measles virus has drawn
great attention in the last decade. A Swedish study suggested that perinatal or in
utero exposure to measles might be related to the increased incidence of Crohn's
disease (141). In a longitudinal study it has also been shown that measles
vaccinated children are more likely to develop Crohn's disease (142). Detection
of paramyxovirus-like particles by transmission electron microscopy suggested
the presence of measles virus in Crohn's tissues (143). However, no viral
genome has yet been extracted from any Crohn's disease tissue (144).
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Bacterial aetiology of ulcerative colitis
Since the description of ulcerative colitis in the early nineteenth century, debate
continues on the aetiology of ulcerative colitis (145). The introduction of tinned
foods and the use of preservatives have not been ruled out as a possible cause
of the disease. In the early nineteenth century, ulcerative colitis was believed by
some investigators to be an atypical form of dysentery and some investigators
also considered the disease to be psychosomatic. No claim for the presence of
any specific microorganism in the affected tissue was substantiated. As the
normal colon harbours so many bacteria, it has been postulated that a commonly
occurring bacterium in the intestinal lumen is probably playing a key role in the
initiation of the disease. Of these microorganisms, Escherichia coli is considered
to be a prime candidate because of its continued mutations and probably
releasing some products that might damage the mucosa (146). Strains of E.coli
were isolated from ulcerative colitis patients which was different from those
isolated from patients with normal colon but this was not universally accepted as
significant because of the isolation from established cases after relapse which
can not explain the primary event of disease (147). However, it has been
suggested that any mutant strain may damage the gastrointestinal mucosa by
liberating certain enzymes or products yet to be identified. The increased
expression of adhesins by colonic mucosa in ulcerative colitis patients
strengthens the view that E.coli in colitis patients probably may have a tendency
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to adhere more to the colonic epithelial cells compared to normal and that may
initiate the mucosal damage (148). The results of a clinical trial of tobramycin, an
effective drug against E.coli, support this view (149). Our clinical knowledge has
advanced on ulcerative colitis since Sir Arthur Hurst first made a complete
description of the disease differentiating it from bacillary dysentery (129).
However, the chronic nature of the disease remains unexplained. An infective
aetiology responsible for the initiation of inflammatory bowel disease has not
been excluded and the search continues (150).
Genetics of Inflammatory Bowel Disease
It is widely believed that genetic factors are involved in the pathogenesis of
inflammatory bowel disease. In the following paragraphs, studies related to
genetic predisposition in Crohn's disease and ulcerative colitis are discussed.
Genetics of Crohn's disease
Several lines of investigation indicate that genetic factors are involved in the
pathogenesis of IBD. A higher prevalence of Crohn's disease among Ashkenazi
Jews of middle European origin compared to other parts of the world supports
this view (151). Family studies have documented a higher incidence of Crohn's
disease among relatives of patients with inflammatory bowel disease (152,153).
With one exception (154) most studies have ruled out Crohn's disease as X-
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linked (155). A Swedish twin study has found that -40% unselected monozygotic
twins were concordant for Crohn's disease compared with -6% monozygotic
twins in ulcerative colitis (156). A recent Scottish study has shown a 50%
concordance for Crohn's disease between monozygotic twins, 3% for dizygotic
twins and 2% for other siblings (157). It therefore appears that Crohn's disease
has a greater genetic element than ulcerative colitis, but the concordance rate
even among monozygotic twins is less than 100% which cannot be consistent
with a Mendelian autosomal recessive mode of inheritance.
Inherited chromosomal fragility found in Crohn's disease patients compared to
normal also indicates a genetic involvement of the disease. Chromosome 6 and
the major histocompatibility complex have been considered as the locus of a
susceptibility gene by segregation analysis (158). In studies based on
segregation analysis and familial aggregation of Crohn's disease, Monsen and
co-investigators concluded that Crohn's disease is an oligogenically inherited
disease (152).
Experimental models of inflammatory bowel disease point to an unregulated
immune response to unidentified luminal antigens in inducing chronic
inflammation in genetically susceptible subjects. Microbial antigens are likely to
trigger the unregulated immune response and there could be a critical link
between environmental factors and the genetic make-up of an individual in the
pathogenesis of Crohn's disease. Therefore it has been suggested that luminal
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factors such as bacteria or their products must play a role in the clinical
expression of Crohn's disease.
Genetics of Ulcerative colitis
For many years ulcerative colitis was believed to be a familial disease but there
is no absolute evidence in support of this theory. However, there is general
agreement that a familial association exists within first-degree relatives. It has
also been found that affected family members may have either ulcerative colitis
or Crohn's disease (159,160).
Genetic anticipation: Children in affected families develop disease at an earlier
age compared to their affected parents and this has been observed in IBD. This
age onset supports a high degree of concordance among affected siblings, and
this is also true for the site of inflammation and the type of clinical presentation
(161).
Genetic susceptibility is partly understood in ulcerative colitis (156). Early
European studies documented increased frequency of HLA-A11 and HLA-A7 in
UC and a decreased frequency of HLA-A9 in CD (162). Studies in Japanese and
Jewish patients found an association between ulcerative colitis and the 1502
allele of human leukocyte antigen HLA - DR2 (163). This allele is almost non¬
existent among northern Europeans. Genotype studies can predict extent or
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severity of disease in a defined population. This finding indicates a genetic
diversity in IBD (164).
Recent studies have identified linkages to specific chromosomes. A French study
observed a susceptibility locus on chromosome 16 (165), and linkage studies in
Britain have produced evidence for susceptibility for both CD and UC on
chromosomes 3, 7, and 12, suggesting that these are distinct disorders sharing
some susceptibility genes (166). In a recently published article Hugot et al. [2001]
and Ogura et al. [2001] have reported that mutations of the gene encoding NOD2
are strongly associated with the development of Crohn's disease (167,168).
These findings will provide new insight into potential IBD genes that may be
involved in pathogenesis of IBD.
However, the rapid increase in incidence of Crohn's disease during the last few
decades cannot be explained by changes in genetic makeup of stable
populations during the same period (169). Therefore, non-genetic i.e.,
environmental factors are presumably also involved in the pathogenesis of IBD.
Luminal factors and Inflammatory Bowel Disease
Investigations on the bacteria and bacterial products within the gastrointestinal
tract indicate that these microorganisms can breach the intestinal mucosal barrier
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and enter the intestinal epithelium (170). In animal studies it has been observed
that microparticles can cross the epithelial barrier too (48). In the human
intestine, non-digested microparticles have been observed (17). No single factor
has yet been confirmed for the initiation process of inflammation in IBD.
However, persistence of inflammation might be due to any of several factors
either alone or in combination.
Lipopolysaccharide and mucosal inflammation
It is widely accepted that genetic susceptibility and environmental factors are
involved in the pathogenesis of inflammatory bowel disease. Genetic knockout
animal models do not develop overt manifestations of Crohn's disease and
ulcerative colitis in a pathogen-free environment (171,172). It is therefore likely
that bacteria and bacterial products such as LPS are playing a part (involved) in
the pathogenesis of inflammatory bowel disease.
Studies have shown lipopolysaccharide (LPS) found within the intestinal lumen
can recruit neutrophils as well as initiate an inflammatory process (173,174). In
animal experiments it has been demonstrated that injection of bacterial cell wall
products e.g., LPS into the wall of the intestine sets up a chronic inflammatory
condition that resembles Crohn's disease. This of course, bypasses the barrier
function of the intestinal epithelium, but it is interesting that luminal contents of
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the intestine can both initiate and sustain inflammatory responses within the
intestinal wall.
It has been reported that mammalian cells respond to LPS ((175)), a major
component of the outer wall of the bacterial cell wall by activating Toll-like
receptors.(TLRs) ((176,177). In humans, a family of proteins homologous to Toll,
TLRs have recently been described. So far nine human TLRs have been cloned
(TLR1-TLR9) (178). TLR 4, a member of the family of TLRs, is a type I integral
membrane protein that contains leucine-rich motifs on their extracellular portions
and an intracellular signalling domain homologous to that of the IL-1 receptor
(179). In response to LPS, TLR 4 initiates a cascade of serine/threonine kinase
activity that eventually leads to the activation of NF-kB in
macrophages/monocytes. NF-kB activates a variety of inflammatory mediators
and cytokines including tumour necrosis factor-a (TNF-a) and interleukin12 (IL-
12) which are involved in the inflammatory process of inflammatory bowel
disease (180).
Intestinal microparticles- any role in intestinal inflammation?
The finding of inorganic microparticles such as titanium in the human intestine
suggests an unwanted breach of the intestinal barrier that could initiate an
unregulated inflammatory process in IBD (18,181). Shepherd (1987) first
reported the presence of cells containing microparticles in sections of small
intestinal tissue (181). Similar cells were subsequently reported in sections of
both small and large intestine (181,182). Detailed examination of the inorganic
microparticles by confocal microscopy demonstrated their intracellular
localisation and X-ray microanalysis confirmed that the microparticles consisted
of compounds of titanium, silicon, and aluminium of <1 pm in size. It is likely that
these have been ingested as a contaminant or as a result of dietary
contamination (183). Aluminium and silicon occur as silicates/allumino-silicates in
soil throughout the world. Aluminosilicate as kaolinate and titanium oxide in its
polymeric form as anatase are used in the food industry as preservatives. These
inorganic microparticles are highly resistant to degradation. A report from the UK
indicates that the average daily intake of anatase is 5.4 mg/person equivalent to
1012 microparticles/person/day (184). Most studies on microparticle-related injury
have been done in lung tissues and in prosthetic implants and found to be
granulogenic (185,186). Similar studies in intestinal tissues are scanty. It is
important to know the effects that microparticles may produce in the human
intestine. Inorganic microparticles may be inert in isolation but during passage
through the intestinal tract may adsorb luminal contents such as
lipopolysaccharide and this may alter the properties of these microparticles. At
present we lack data on the number of microparticle-laden cells in the human
intestinal wall and information on whether microparticles may have a role in
intestinal inflammation is inadequate.
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Summary
Most of the microparticle uptake studies have been done with the aim of delivery
of a pharmaceutical agent across the gastrointestinal mucosa. No experimental
study in humans on uptake and translocation of non-degradable microparticles
from a possible pathologic point of view has been done. It may be of relevance,
if non-degradable microparticles are taken up by human intestinal mucosa, to
examine the cells involved in this process.
Non-degradable microparticles have been reported in the human intestine and
macrophages retain these microparticles. Macrophages are definitely involved in
the inflammatory process in IBD. No quantitative data on the involvement of
microparticle-laden macrophages in inflamed intestine is available. It is therefore
also important to study the extent of involvement of microparticle-laden
macrophages in human intestine.
It is now established that other than providing nutritional benefit, a small fraction
of intact protein crosses the intestinal barrier but the purpose of this transport is
not known. Any protein or incomplete protein such as prions may be of
significance in contracting the human form of 'mad cow disease'. It is now widely
believed that per oral route of entry of prions is most likely in the pathogenesis of
variant Creutzfeldt-Jacob disease (vCJD). Many studies on the pathogenesis of
vCJD have been conducted in animals by injecting infectious materials either into
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the brain or peritoneum. A large study has been completed in the UK with orally
dosed calves. Similar oral challenge experiments have been done by other
workers, but little research so far been focussed on the cellular site of entry of
prions in the gut or the mechanisms of passage from the gut. It is necessary to
produce evidence that uptake of prions occurs by human intestinal epithelium.
Then it will be necessary to determine the subsequent handling of prions by the
mucosal cells in the intestine.
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CHAPTER 3: MATERIALS AND METHODS
Sections from surgically resected intestine were lightly stained with H & E and
reviewed. Microparticles within the tissues were determined by confocal laser
scanning microscopy, and microparticles in the subcellular structures were
assessed by transmission electron microscopy. The microparticle-laden cells in
the tissues were identified by CD68 antibody specific for tissue macrophages.
Automated image analysis allowed microparticle-laden CD68+ cell areas to be
measured, quantitated and compared in tissues from patients with Crohn's
disease or ulcerative colitis and from control subjects.
Subjects
Biopsies were collected from adult human subjects for culture and
experimentation with fluorescent polystyrene microparticles with or without
lipopolysaccharide of Escherichia coli 055:B5.
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Consent and Ethical approval
Before colonoscopy, either for diagnosis or cancer screening, informed consent
was obtained from subjects to collect biopsies for this research. The Medicine
and Oncology Subcommittee of the Lothian Ethics in Research Committee
approved this study.
Endoscopic biopsies were collected, as stated, from subjects undergoing
colonoscopy for the diagnosis of disease or cancer screening. For IBD biopsies,
areas of the intestine had been assessed for the presence or absence of disease
by an experienced colonoscopist on a scale of 0-3. The scale, 0 = normal, 1 =
mild inflammation with loss of vascular pattern with granularity, 2 = severe
inflammation with contact bleeding, 3 = severe disease with friability, ulcers or
spontaneous bleeding (187). In this study biopsies from IBD patients were
collected from subjects in grade 0 and 1.
The subjects in this study were control subjects and IBD patients. Control
subjects were disease controls and comprised individuals in whom investigation
had been undertaken for gastrointestinal symptoms and with normal intestinal
histology. They comprised patients with irritable bowel syndrome, or patients who
had colonoscopy for cancer screening. Diagnosis of Crohn's disease and
ulcerative colitis was made according to the criteria set out by Binder in 1982
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(188) and Lennard-Jones in 1989 (189). The histories of the patients were
obtained prior to collection of biopsies and subjects were excluded if necessary.
Microparticle uptake study
The aim of this thesis was to examine any uptake of inert microparticles such as
polystyrene latex microspheres by human intestinal tissues. This experimentation
is not ethically permissible in vivo in humans. Therefore organ culture of human
intestinal biopsies was chosen as a feasible way to conduct such an
experimental work. Organ culture of gastrointestinal mucosa has been
successfully applied to study the toxic effect of substances such as gliadin,
deoxycholate or indole, which could not be done in vivo. Similarly organ culture
of respiratory mucosa has been most widely used to study the uptake of
environmental microparticles such as asbestos, polystyrene, diesel particles etc.
which could not be done in vivo, but it is important to understand any pathogenic
effect of these substances.
Organ culture - Culture of human colon biopsies
Organ culture has been defined as a "Tissue culture technique in which the
structure and integrity of an organ can be maintained in vitro with a minimum
outgrowth whilst preserving normal histology". Initially, researchers used flat
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plasma clots as a solid base for growth of embryonic tissues. Thereafter, mature
tissues were cultured using liquid medium in high oxygen concentration (190).
Trowell (1959) pioneered the organ culture technique that could be used to
culture adult animal tissue and his method formed the basis of all subsequent
methods of organ culture (191). Browning and Trier (1969) successfully cultured
adult human intestinal mucosal biopsies for 24 hours (192). Thereafter, almost all
research work on the culture of gastrointestinal mucosa followed their method
with minor modifications.
The basic principle of organ culture is to maintain an explant tissue at the
interface between a fluid culture medium and a gas phase. Explant tissues are
maintained on an iron mesh or filter membrane in a specially designed culture
dish (organ culture dish, Becton Dickinson, UK) in an oxygen-rich environment at
body temperature (37°C). The central well of the culture dish is filled with a
culture medium so as to touch the under-surface of the explant tissue and a thin
layer of the medium is drawn over the apical surface by capillary suction. The
whole system is maintained at 37°C in an atmosphere of 95% 02 and 5% C02.
The most important point for a successful culture of explant tissues is the gas-
fluid interface and optimum oxygen concentration. Hodges et al (1976) observed
that supplementation of Weymouth's MB 752/1 medium with small amounts of
ascorbic acid, ferrous sulphate and hydrocortisone enhanced the preservation,
growth and development of foetal mouse tissue (193). By adding foetal calf
serum, Defries et al (1977) were able to maintain adult mouse colon in organ
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culture for several months (194). Following the same method, it was possible to
maintain adult human colon mucosa for up to 14 days (195).
The technique of Senior et al. (195) was adapted for organ culture of
colonoscopic biopsies. The basic medium used in the present study was as
described by Hodges et al (1976). This comprised Weymouth's MB 752/1
medium (ICN, UK) supplemented with 10% foetal calf serum (ICN, UK), ascorbic
acid 300 pg/ml (Sigma, UK), ferrous sulphate 0.45 jug/ml (Sigma, UK), L-
glutamine 200 mM (Sigma, UK), penicillin 5000 i.u/ml (Sigma, UK), streptomycin
5000 pg/ml (Sigma, UK) and gentamicin 50 pg/ml (Sigma, UK) (196).
A second modification to the technique of Senior et al was the use of a sealed
modular incubator chamber (Bilrups-Rothenburg Corporation, California, USA).
This is a Plexiglas chamber fitted with trays that can hold up to 30 organ-culture
dishes. Humidity was maintained by placing sterile water in a petri dish at the
bottom of the tray and the entire chamber was gassed with a mixture of 95% 02
and 5% C02 and sealed at a pressure of up to 2 atmospheres. It is specifically
designed to allow rapid exchange of gases and the gas phase reaches an
equilibrium within 20 seconds when flushed at 5 L/min. All biopsies were blinded
after culture for 24 hours and sections were coded.
No organ culture model has been described for the study of uptake of
polystyrene microparticles in human intestinal tissues. Therefore, initially it was
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necessary to be acquainted with the methods of culturing human intestinal
tissues, and then to adapt these for the present study. The first difficulty was that
tissues grown on iron grids were not suitable to study the uptake of particles. The
pore size of these iron grids ~1mm allowed the particles (2 pm) to fall through.
Therefore, the first modification needed was the use of cellulose filter
membranes in place of iron grids. Immediately after collection biopsies tend to
curl-up. It was observed that this curling could be prevented if biopsies were
placed on a flat sterile petri dish with a drop of medium. The surface tension of
the medium flattened the biopsies on the petri dish and facilitated spreading on
the filter membranes. After trying filters with different pore size it was observed
that filter membranes of 0.45-pm pore size were most suitable to study the
uptake of polystyrene microparticles. The tissues grew well on these and their
viability was assessed by studying the morphology and uptake of the thymidine
analogue bromodeoxyuridine by the cultured tissues. For particle uptake studies
it was also necessary to study the integrity of the tissues by electron microscopy.
In this part of the study Dr. Margaret Mclntyre was consulted. The development
of this original organ culture model for the study of the uptake of polystyrene
particles in cultured human intestinal tissues took about 3 months to set up in a
reproducible form.
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Survival of tissues in organ culture
Various methods have been applied to assess the survival of explant tissues in
organ culture. Good morphological preservation, steady-state protein synthesis
and enzyme activities indicate survival of tissues. Morphology of the tissues is
usually examined by light microscopy but examination of cultured tissues by
transmission electron microscopy provides the opportunity to evaluate the
integrity of the epithelium, activity of the goblet cells, and organisation of the
subcellular structures. Enzymatic activities such as alkaline phosphatase and
sucrase of the brush border are also used to assess the metabolic functions of
the cells in organ culture. Incorporation of tritiated thymidine or thymidine
analogue bromodeoxyuridine by the dividing cells is the most frequently used
method to assess the viability of the tissues in organ culture and indicates the
synthetic ability of the undifferentiated dividing cells .
Bromodeoxyuridine
Bromodeoxyuridine is a thymidine analogue and is incorporated as tritiated
thymidine [3H] in deoxyribonucleic acid (DNA) of the cells in the S-phase of cell
division. Monoclonal antibody specific to bromodeoxyuridine enables the
detection of cells that have been dividing.
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Polystyrene microparticles
Fluorescent, plain (non-ionic) mono-disperse polystyrene microparticles
(Polysciences, Warrington, USA), 2 pm in diameter were used in experiments on
uptake. The microparticles have 2.5% solid content with a yellow-green excitation
with emission minimum and maximum of 545 and 610 nm. The stock suspension
of microparticles was diluted in sterile de-ionised water to obtain a concentration
of 5.68 X 106 per 0.1 ml.
Quantitative analysis of microparticle uptake
Numerous methods have been applied to evaluate microparticle uptake and
translocation in tissues. Of the various methods in detecting microparticles after
oral or intestinal administration, two methods have been widely used in studies
using polystyrene microparticles. Each method has its advantages and
limitations.
1. Quantitation of microparticles in macerated tissues: the major strength
of this technique is that data are gathered from a large mass of tissue. From
the view of microencapsulated delivery of a drug or vaccine to a tissue, this
may be more informative. A major weakness of this method is lack of
information at the cellular level, which would be more relevant in studying
the potential for pathological consequences. A particular problem in studies
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of the uptake by gastrointestinal tissue is that it is impossible to ascertain,
even after thorough washing, whether counted microparticles were located
within the tissue or were associated with the mucosal exudate attached to
the apical surface of the intestinal epithelial cells.
In situ visualisation of microparticles and quantitation: this method can
be applied to various forms of microscopy to localise microparticles within a
tissue. Of the various microscopical techniques, confocal laser scanning
microscopy provides the facility of optical sectioning (<1 pm), a convenient
means of locating microparticles within frozen tissue. Confocal imaging of
cryosections minimises the possibility of artefactual movement of
microparticles during tissue preparation and provides unequivocal evidence
of the location of microparticles within a thick (15 pm) tissue section. In
addition, merging confocal images allows the relationship between
microparticles and tissue site to be determined. Furthermore, associated
epifluorescence microscopy provides a sensitive method for quantitating
fluorescent microparticle uptake by optical counting of microparticles in situ.
Electron microscopy (EM): EM is used to determine cellular and
subcellular location of microparticles. Ruska and Knoll first constructed the
transmission electron microscope (TEM) in 1931 (197) and since then many
modifications and improvements have been made to study subcellular
structures in detail. The basic principle of an electron microscope is that a
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high velocity homogeneous electron beam passed through an ultrathin
tissue section producing an emergent beam of transmitted electrons that is
then refracted by a system of lenses to form a magnified, two dimensional
image of the specimen. The magnification, which can be increased to ~ 500
000 X, allows the examination of minute details of a structure in biology and
reveals subcellular structures in tissues.
Most microparticle uptake studies have used fluorescent polystyrene
microparticles with detection at tissue level by confocal microscopy and at
cellular and subcellular level by electron microscopy (48,52).
Microparticle-laden macrophages
Paraffin-embedded sections from surgically resected intestine from patients with
Crohn's disease or ulcerative colitis or from control subjects with distal bowel
cancer were collected. An unaffected part of the cancerous intestine was used
for the controls. Selected specimens were from ileum, ileocaecal valve and
colon, and were macroscopically normal. Microscopically, tissues were mild to
moderately inflamed in Crohn's disease and ulcerative colitis. Controls were free
from polymorph infiltrates, significant lymphoid or plasma cell infiltrates, fibrosis,




Sections were deparaffinized and antigen was unmasked at high temperature by
exposure to microwave at 800 W for 20 min. Tissue endogenous peroxidase
activity was blocked with 3% hydrogen peroxide. Then sections were incubated
with 20% filtered normal rabbit serum in 0.05 M Tris buffered saline (TBS), pH
7.6 followed by incubation with a range of mouse monoclonal anti-human CD68
antibody (PG-MI, Dako, UK). Sections were then incubated in rabbit anti-mouse
biotinylated horseradish peroxidase (HRP) antibody (IgG) at a dilution of 1:300.
Then sections were incubated with streptavidin/biotin-peroxidase. Sections were
rinsed and washed in TBS after each step. Highly chromogenic brown reaction
products were produced by incubation with 3,3' - diaminobenzidine (0.05%) in
0.01% hydrogen peroxide in TBS. Sections were counterstained with 0.01%
methyl green for detection of brown stained CD 68+ cells (tissue macrophages)
for image analysis. Serial sections from surgically obtained tonsils were prepared
as positive controls and sections stained without primary antibody were used as
negative controls. In CD68 positive sections, cytoplasm appeared as dark brown
and in negative sections cytoplasm was not stained.
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Serial dilutions of CD68 antibody were tested from 1:10 to 1:320. The optimal
antibody dilution was assessed by two observers who agreed that 1:40 gives
uniform staining without background staining.
Streptavidin/biotin-alkaline phosphatase method
Serial sections were also immunostained by alkaline phosphatase method to
enumerate CD68+ cells with inorganic microparticles by image analysis. In brief,
after incubation with primary antibody (mouse monoclonal antihuman CD68, PG-
Ml, Dako, UK) at dilution 1:40, sections were then incubated with rabbit anti-
mouse biotinylated alkaline phosphatase at a dilution of 1:300. This step was
followed by incubation with streptavidin/biotin-alkaline phosphatase. After each
incubation sections were rinsed and washed in TBS. Highly chromogenic bright
red reaction products were produced by incubation with New substrate system
(Dako, UK). Sections were counterstained with Harris haematoxylin which helps
to detect blue stained nuclei and black microparticles on a pink-red background,
and facilitates enumeration of CD68+ cells with or without microparticles by
automated image analysis. Positive controls were surgically resected tonsils and
negative controls were sections without primary antibody as before.
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Image analysis of tissue macrophages
Qualitative descriptions of tissues routinely made by histologists have limitations
for quantitative analysis. The measurement of microscopic images of tissues
(histometry) facilitates the quantitative analysis of tissues and can be done in
various ways:
1. Measurements could be made by reflecting an image from a microscope
slide projector on a screen or on a paper and measurements can be made
onto a measuring grid drawn on cardboard or on a transparent material.
2. The use of eyepiece graticules allows quantitative measurement of tissues.
This method was most widely used, before the development of
computerised image analysis.
3. Computerised image analysis: In recent years, this is increasingly used in
research and is now the most convenient and accurate method for
quantitative analysis of tissues. A specially designed television camera
scans microscopic images and sends signals to a detector unit. The
detector unit is a densitometer which classifies each image according to
grey level and allows densitometric data to be determined as well as
morphometric parameters. By pattern recognition it is possible to measure
two parameters simultaneously. This pattern recognition capability allows
the exclusion of background extraneous matter that would otherwise be a
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source of error. The electrical profiles of the features are fed to a computer
and analysed (198).
In this thesis, computerised image analysis (Leica, Germany) was used for the
quantitative analysis of microparticle-laden macrophages in resected human
intestine.
X-ray microanalysis
To determine the chemical composition of the microparticles in tissues, energy-
dispersive analysis of X-rays (EDAX) was done in association with transmission
electron microscopy.
EDAX is a modification of an electron microscopy technique and can be used to
undertake a chemical analysis of the specimen. Basically, when a high-energy
electron in the probe strikes a thin section interactions between the primary
electrons of the probe and atoms in the specimen occur. Transmitted electrons
may pass through the specimen unchanged, or they can be scattered through
different angles. These transmitted and scattered electrons are used to produce
images of the ultrastructural characteristic of the specimen.
Secondary electrons are also produced when electrons within the specimen are
ejected from their atoms by collisions with a high-energy probe electron. These
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secondary electrons have a low energy and can provide information on the
composition of the surface of the specimen. Secondary electrons are utilised in
scanning electron microscopy.
Atoms consist of the nucleus, which is surrounded by electrons circulating in
orbits. Each orbit corresponds to an energy level of the electrons. The number of
these orbits and their energy levels depend on the size of the atom. They are
grouped in units called shells, each shell has a number of energy levels.
Elements are characterised by their nuclear charge and the energy distribution of
their electrons. The shells are noted by the letters K, L, M, etc. and heavier
elements have large atoms with large numbers of electron orbits and shell units.
In the analytical mode, it is the characteristic X-rays, that are produced when an
electron from the electron probe collides with, and removes from its orbit, an
electron previously bound to an atom. The removed electrons are replaced by
other electrons from higher shells, and in doing so a precise amount of energy in
the form of a spectrum of X-ray is liberated. The spectrum is very characteristic
for an element and provides information on the element involved in the
interaction. The X-rays are collected and analysed in an energy dispersive X-ray
analysis system. Different types of X-ray analysis can be performed by this
technique. The most commonly used techniques are: (a) point analysis, a
complete system to analyse all the elements present at one particular point which
can be as small as 1 nm; (b) X-ray distribution analysis or mapping, for
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determining distribution of up to sixteen elements; (c) X-ray line scans to
determine variations in the amount of a single element in relation to their location
over a specimen; and (d) quantitative analysis to determine the concentration of
a particular element.
EDAX in combination with transmission electron microscope enables directly to
image ultrastructural detail, elemental composition of selected particles. The
spectrum of an element is compared against standard spectra. Spectra for every
element in the periodic table are stored in a data base within the software used
for the analysis. The test spectrum is compared with this data. Confirmation of
the presence of specific elements is done by taking a background reading from a
resin not containing metallic particles.
Analysis of inorganic microparticles in this thesis has been done in a
transmission electron microscope (TEM Philips CM120, Eindhoven, Holland) and
EDAX (EDAX DX4 Eindhoven, Holland) attached to it. Software that has been




The data were entered in a personal computer and analysed by SPSS PC+
program (SPSS PC+ Inc. Chicago, IL, USA). Graphs and bar charts were
prepared by Microsoft Excel program (Microsoft Corporation, USA).
The mean of a series of observations from a single case was taken to represent
the value for that observation and was included in the final analysis. Descriptive
statistics included mean and standard error of the mean of the parameters in the
analysis. Values from specific subgroups of patients were then compared using t-
test. A probability (p) value of < 0.05 was considered as significant.
Data relating to labelling indices of cells as assessed by uptake of
bromodeoxyuridine (BrdU) was presented as mean and standard error of the
mean, and was compared using t-test.
The data regarding immunostained macrophages, microparticle laden-
macrophages and macrophage areas were analysed by t-test. The mean of
observations from a case was included in the final analysis. Descriptive statistics
included mean and standard error of the mean of the parameters in the analysis.
A probability (p) value of < 0.05 was considered as significant.
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The value for uptake of fluorescent polystyrene microparticles (microparticle
count/mm2) were presented as mean and standard error of the mean and the
comparison between groups was assessed by t-test. A probability (p) value of <
0.05 was considered as significant. The mean of observations from a case was
included in the final analysis.
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CHAPTER 4-METHODS: ASSESSMENT OF SURVIVAL OF ORGAN
CULTURE OF HUMAN COLON
Introduction
Organ culture of human intestinal mucosa was introduced by Browning and Trier
in 1969 (192), and since then this technique has been widely applied to
investigate structure and function of human intestinal mucosa in vitro. It has been
observed that in this technique intestinal mucosa remains viable for 24 hours with
good morphological preservation and steady-state protein synthesis in man and
animals (199-202). The continuing synthesis of deoxyribonucleic acid (DNA) by
the epithelial cells indicates their physiological state.
DNA is synthesised during the S - phase of cell division when doubling of the
genome takes place. In 1951, Howard and Pelc studied cell division (203) and
they observed that the S-phase is followed by a G2 or second gap phase during
which biochemical events take place in preparation for cell division. G2 phase is
followed by mitosis after which cells enter G1 or first gap phase during which
cells proceed to further division or quit cell division. Cells that are not in the
process of division are termed as GO cells (204). GO cells may proceed for
differentiation or may re-enter the process of cell division.
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Synthesis of DNA in a tissue can be studied using a variety of techniques,
namely scoring of the mitotic index, or measuring the uptake of thymidine
analogues such as tritiated thymidine (3H-tdr) by autoradiography or scintillation
counting, or by determining the DNA content of the cells by microdensitometry or
flow cytometry. All of these methods have limitations and advantages. (205).
In early cell cycle studies, tritiated thymidine [3H] was the most commonly used
technique and was largely restricted to studies in animals. The thymidine
analogue bromodeoxyuridine (5-Bromo-2-deoxyuridine, BrdU) is also
incorporated as thymidine in the DNA of the dividing cells and is free of
radioactivity. Development of a monoclonal antibody to bromodeoxyuridine by
Gratzner has opened up a much simpler immunohistochemical technique to
study cell kinetics (206). BrdU labelling has been found to be comparable to
tritiated thymidine labelling both in vivo and in vitro (207). BrdU is highly specific,
without false background positivity, and can be detected at very low levels. In the
past, most of its use was in flow cytometry. In vivo labelling of dividing cells in
man was reported by Khan et at (208) and in vitro labelling of dividing cells in
human biopsies was reported by Risio et al (209).
Detection of the S-phase of cell division by bromodeoxyuridine has become a
widely applied method for determining the viability of tissues in culture and cell
proliferation studies. However, application of this method has been mostly in flow
cytometry studies, though initial studies with bromodeoxyuridine were mainly
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concerned with frozen tissues and used immunofluorescence microscopy (210).
The BrdU technique of detecting cells in S-phase was advanced by Morstyn et al
(1986) who worked with ethanol-fixed tissues (211). Suguhara et al developed an
enzymatic pre-digestion method to expose the BrdU binding site in formalin-fixed
tissues (212). It has been found that BrdU labelling, i.e., in the S-phase of cell
division, is best achieved by fixing the tissues in Carnoy's fixative that preserves
the nuclear structure as well as allowing paraffin wax processing (213).
Aims
The aims of the present study was to assess survival of the human colonic
biopsies in short-term organ culture by evaluating incorporation of
bromodeoxyuridine in the dividing crypt cells and to compare results with in vivo
bromodeoxyuridine labelled cells in murine colon.
Materials and methods
Development of positive control - Mice
In developing the immunohistochemical method, CBF mice were used as a
positive control. CBF mice housed in standard laboratory conditions were
labelled by intraperitoneal injection of 50 pig/kg of bromodeoxyuridine (Becton-
Dickinson Antibody Data Sheet) 12 hours before sacrifice. The large intestines
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were removed and fixed in Carnoy's fixative for 12-16 hours followed by in 99%
IMS for another 12 hours and processed in paraffin wax. After embedding, 5 pm
sections were cut in a microtome (Leica, Germany) and plated on slides coated
with poly-L-lysine (Sigma, UK).
Immunohistochemical detection of bromodeoxyuridine labelled cells in
mice
For immunohistochemical staining, paraffin embedded sections were dehydrated
by serial immersion in Histoclear, 2 changes for 5 minutes, followed by industrial
methylated spirit for a further 10 minutes. Sections were then placed in 1 %
hydrogen peroxide in methanol for 20 minutes to block tissue endogenous
peroxidase activity. After washing in running tap water, sections were placed in
1N HCL acid at a temperature of 60°C for 8 minutes. Treatment with acid
releases purines (adenine and guanidine) from the double helix DNA and
exposes the aldehyde group of deoxyribose sugars which includes bound BrdU
making it accessible to the BrdU antibody (Becton Dickinson). After rinsing in
running tap water for 5 minutes, sections were blocked with a 1:4 dilution of
normal rabbit serum in Tris buffered saline (pH 7.6) for 10 minutes. Thereafter
the slides were drained off and a range of dilutions of anti-BrdU antibody
(monoclonal) was applied for 60 minutes. The slides were then rinsed in a stream
of TBS and washed in a rocker for 5 minutes. The sections were then incubated
with biotinylated rabbit anti-mouse immunoglobulin in a dilution of 1:300 for 40
min. After washing as before, the sections were incubated in avidin/biotin-
peroxidase complex (ABC, Dako, UK) in TBS for 30 minutes. Finally the sections
were incubated in diaminobenzidine (DAB) solution at concentration of 0.5 mg/ml
for 10 minutes. Sections were again rinsed in running tap water and
counterstained in Harris haematoxylin for 5 minutes, followed by acid alcohol and
lithium carbonate. After dehydrating through graded alcohol, clearing in
Histoclear and xylene, sections were mounted in synthetic resin (DPX). In BrdU-
positive sections, nuclei appear as dark brown and in negative sections appear
as pale blue. Serial dilutions of anti BrdU antibody were tested from 1:25 to
1:800. Optimal antibody dilution was assessed subjectively by two observers who
agreed that 1:200 gave optimal uniform staining without background staining.
Subjects
Biopsies from the sigmoid colon were taken from each subject with informed
consent who were undergoing colonoscopy either for diagnosis or cancer
screening in the fasting state. All patients were fasted from midnight as required
for the purpose of colonoscopy. The Medicine and Oncology Subcommittee of
the Lothian Ethics in Research Committee had approved this study.
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Culture medium
The culture medium comprised Weymouth's MB752/1 medium (ICN, UK.
Catalogue No. 252254), supplemented with 10 % foetal calf serum (ICN, UK.
Catalogue No. 2910154), L-glutamine 200 mM (Sigma, UK. Catalogue No. G-
7513), ascorbic acid 300 pg/ml (Sigma, UK. Catalogue No. A-4544), ferrous
sulphate 0.45 pg/ml (Sigma, UK. Catalogue No.F-8633), penicillin 5000 i.u. /ml,
streptomycin 5000 pg/ml (Sigma, UK. Catalogue No.P-4458), and gentamicin
50pg/ml (Sigma, UK, Catalogue No. G-1272).
Organ culture of human colon biopsies - protocol
Colonoscopic biopsies were taken between 9 and 11 am to exclude any
theoretical effects of diurnal variation. Immediately after removal, biopsies were
transported to the laboratory, which is close to the endoscopy suite. The
transport was done in complete medium, pre-gassed with 95% 02 and 5% C02 at
37 °C and the tissues were established in organ culture within 10 minutes of
biopsy. In brief, after washing in warm medium, biopsies were oriented on
Millipore filters (pore size 0.45 pm, diameter 25 pm, Millipore Corporation,
Bedford, MA, USA. Catalogue No. HAWP 02500) with mucosal surface up under
a dissecting microscope (Watson, Barnet, England) and the biopsy was
completely flattened; (it usually tends to curl up after excision). The filter
membrane was then placed on the rim of organ culture dishes (Falcon, Becton
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Dickinson UK Ltd. Cat. # 3707) 5.5 cm in diameter with a central 2 cm well in
which 1 ml of complete medium with BrdU was added. In our laboratory, it has
been demonstrated by a series of experiments by Wilson et al (1990) that
bromodeoxyuridine at a concentration of 100 pM gives optimal labelling of the
dividing cells at 10 pi /ml of complete medium (196). The central well of the organ
culture dishes is surrounded by an outer well in which 1 ml of 0.9% NaCI solution
was added and covered. The dishes were then placed on a plastic tray in a
Plexiglas modular chamber [Bilups-Rothenburg™, California, USA] and gassed
with a mixture of 95% 02 and 5% C02 for 5 minutes prior to sealing the outlet of
the chamber until the pressure inside the chamber rose to 2 atmospheres. Then
the chamber was placed in an incubator at 37°C for periods of up to 24 hours.
After 24 h, explant tissues were fixed in Carnoy's fixative for 12-16 hours followed
by immersion in 99% IMS for another 12 hours and processed in paraffin wax.
To measure the labelling index and the position of the proliferative cells within the
crypt, each biopsy was embedded on the edge so that subsequent tissue
sections are cut at 90° to the horizontal plane of the crypts. All sections were cut
on a standard staged microtome (Leica, Germany) at a thickness of 5 pm and
placed on slides coated with poly-L-lysine (Sigma UK). The slides were coded
and examined blinded.
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Immunohistochemical staining of human explant tissues
Five-micron sections of the explant human colon tissues were stained by
avidin/biotin-peroxidase (ABC kit, Dako, UK) technique as described above. In
brief, sections were de-waxed, passed through Histoclear (2 x) and graded
alcohol 99% IMS, 70% alcohol for 5 minutes in each step. Next, sections were
incubated for 20 minutes in 1% hydrogen peroxide (H202) in methanol to block
tissue peroxidase activity. After washing in Tris buffered saline (TBS) at pH 7.6,
DNA (deoxyribonucleic acid) was denatured by immersing sections in 1N HCL at
60°C for eight minutes to expose bound bromodeoxyuridine for
immunohistochemical staining. Tissue sections were successively incubated at
room temperature in 20% normal rabbit serum in TBS (NRS: TBS) at a dilution
1:4 for 10 minutes, and in 1:200 mouse monoclonal anti-BrdU (Becton-Dickinson)
for 60 minutes, then in 1:300 biotinylated rabbit anti-mouse immunoglobulin for
40 minutes, and finally in streptavidin/biotin-peroxidase complex for 30 minutes.
After each step, sections were rinsed in TBS and finally sections were incubated
in 0.05 M TBS containing 0.5 mg/ml diaminobenzidine for 10 minutes. Sections
were counterstained with Harris haematoxylin, dehydrated through graded
alcohol and cleared in Histoclear and were mounted in synthetic resin (DPX).
Immunohistochemically, BrdU-stained sections were systematically reviewed for
crypt architecture, epithelial integrity, nuclear orientation, oedema and cell debris
99
in the lamina propria, any crypt necrosis and amorphous material surrounding the
crypts.
Scoring of BrdU labelled cells
Four well-oriented tissue sections were examined from each biopsy and four
longitudinally sectioned crypts from each section were scored for BrdU labelling
under a light microscope at a magnification of x 400. Total numbers of cells, and
the numbers and positions of BrdU positive cells of each hemicrypt were directly
keyed to a microcomputer for further analysis. The labelling index (LI) for each
crypt was determined by estimating the percentage of BrdU positive cells out of
the total number of cells within that column. The total number of positive cells
obtained for each four crypts was used to calculate the mean % LI for each
individual biopsy. The control Mouse BrdU-labelled sections [Figure 4.1] were
scored in a similar way.
Statistics
Mean labelling indexes were compared by Students' t-test using SPSSPC+




Biopsy specimens were obtained from four subjects with diagnosis of irritable
bowel syndrome and one normal for cancer screening. The subjects were 1 male
and 4 females with a median (range) age of 59 (35-74).
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Figure 4.1. In vivo bromodeoxyuridine labelled (brown) murine
colonic crypt cells. Scale bar = 20 |im
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Figure 4.2. In vitro bromodeoxyuridine labelled (brown) human
colonic crypt cells. Scale bar = 20 jim
Survival of the biopsy specimen was found in all specimens of cultured tissue
examined for up to 24 h and was determined by retention of normal morphology
of the tissues and the continued appearance of mitotic cells [Figure 4.2], Crypt
architecture was maintained well in human colon biopsies subjected to in vitro
organ culture. Variable amounts of heterogeneous material, presumably
consisting of mucus and cellular debris, were noted on the surface of the
epithelium. Cells in the lamina propria appeared normal. Many mitoses were
present in the crypts, even after culture for 24 hours and mostly were present







Figure 4. 3: Mean labelling indices (% LI) of colonic crypt cells.
Control = mouse; study = human.
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Figure 4.4. Light micrograph of human colonic mucosa.
Counter stained with H & E. Scale bar = 20 pm
Figure 4.5. Electron micrograph of human colonic
epithelium showing goblet cell with a nuclei and
filled with mucus. Scale bar = 5 pm
The total number of BrdU-labelled cells in the subjects studied was 60 and the
total number of cells was 316. In the mouse studies, BrdU-labelled cells were 78
and the total number of cells was 418. The percentage of labelled cells ranged
from 2-5 per hemicrypt at 24 hours in cultured human mucosa and 3-5 in murine
colon. The mean (SEM) labelling index (LI) in human biopsies was not
significantly different from that found for the mice: 17 (0.8) vs. 18 (0.8), p = 0.1
[Figure 4.3],
Light micrograph (H & E stained) and electron micrograph of human colonic
mucosa have been presented in figure 4.4 and figure 4.5.
Discussion
In this study, it appears that in vitro BrdU labelling of human colon crypt cells is
analogous to in vivo labelling of mouse colon cells. In animal studies it has been
documented that the lower two thirds of the colonic crypt is the principal site of
cell division (214). In the upper third of the crypt, fully differentiated cells lose
their capacity to proliferate and do not synthesize their DNA in normal conditions.
This study confirms that observation. The values obtained for human colonic
mucosa are similar to those reported using 3H-Thymidine (215).
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Most organ culture studies of human colon have been conducted to determine
the proliferation of cells in colon cancer and few studies have been done to study
the toxic effect of gliadin in vitro. Cole et al in their work to develop in vivo flash
labelling methods in advanced colon cancer subjects have demonstrated uptake
of 3H-thymidine by the cells at the base of the crypt and gradual progression of
labelled cells towards the lumen (216).
Incorporation of BrdU into the nuclei of undifferentiated crypt cells provides
evidence that epithelial cells were actively synthesising deoxyribonucleic acid.
The presence of mitoses in crypts of biopsies continued in vitro for 24 h and
migration of BrdU-labelled cells from crypt base to the lumen indicate epithelial
cell proliferation and migration in this organ culture technique. The rate of
migration of BrdU-labelled epithelial cells in vivo in mice and in cultured human
colon epithelium in vitro was not significantly different. In both situations, cells
have migrated from the crypt base.
The viability of tissue in organ culture for a prolonged period is dependent on
detailed technique. In organ culture, the tissue sample is not immersed (as in
tissue culture) but rather it is placed on the surface of the medium and the
medium seeps over the specimen by capillary action. This allows better
oxygenation of the tissue and survival is prolonged.
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In the present study, human colon biopsies were successfully cultured for up to
24 h and the culture methods have been validated for subsequent studies in
modified conditions.
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CHAPTER 5: EFFECTS OF LIPOPOLYSACCHARIDE ON ORGAN CULTURE
OF HUMAN COLON
Introduction
Lipopolysaccharides (LPS), also called endotoxin, are elements of the cell wall of
gram-negative bacteria. Under physiological conditions, the gastrointestinal
epithelium is considered to be a barrier to these toxins(217). The epithelial barrier
is maintained by a delicate balance between proliferation of progenitor cells in
the crypts and shedding of fully differentiated functional epithelial cells at the top
of the villi or crypts (218). The functional cells of the epithelium are located at the
top of the crypts and once they have fulfilled their differentiated function, the cells
senesce and are shed off into the lumen as a programmed cell death or
apoptosis (106). There is a continuous loss of epithelial cells, and in order to
maintain epithelial integrity and sustain the epithelial barrier, the lost cells must
be replaced at an equal rate. The epithelium of the gastrointestinal tract is one of
the most rapidly renewing tissues and has a very large number of cycling cells.
The proliferating cells are located in the bottom two-thirds of the crypts referred
to as the proliferative zone. In the healthy state, the rate of cell production and
loss is balanced under stringent conditions. Studies have shown that in
physiological condition, the undifferentiated cells in the basal crypts have the
capacity to proliferate but fully differentiated mature cells in the upper parts of the
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crypts lose their capacity to proliferate (196,215,219). The physiological factors
regulating proliferation of undifferentiated cells in the crypts are largely unknown.
It is believed that a variety of growth factors, cytokines, hormones, and luminal
nutrients are regulating factors (220,221).
The large intestine hosts a huge number of indigenous bacteria and is exposed
to potentially pathogenic bacteria. Extensive studies have suggested that gram-
negative bacteria may interact with the intestinal epithelium by attachment to
membrane glycoproteins or glycolipid receptors and through this mechanism
induce signal transduction to modify effector responses in epithelial cell structure
and /or function for their own purposes (222).
Although endotoxin is a large macromolecule, it has been demonstrated that
bacterial lipopolysaccharide can cross the intestinal epithelium and is capable of
altering the function of the epithelium. In vitro studies have demonstrated that
endotoxin alters the secretory properties of the intestinal epithelium. LPS is also
a potent stimulator of mucosal cells and liberates proinflammatory cytokines and
growth factors. It has been observed that LPS increases secretion of cytokines
by activating NF- kB (223). Intestinal epithelial cell homeostasis depends on a
delicate balance between pro- and anti-inflammatory cytokines produced in the
mucosa. Endotoxin may not have an impact on terminally differentiated intestinal
epithelial cells but it may have an effect on the progenitor cells residing in the
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crypt. LPS has also been reported to increase proliferation of nasal epithelial
cells in the rat (224).
Organ culture provides a good model to study proliferation of crypt cells and has
been widely used to study tumourogenesis in the human colon. However, studies
on the effect of endotoxin on human crypt cell proliferation are lacking. The aim
of the present study was to determine whether endotoxin may have any effect on
epithelial cell proliferation and morphology in organ culture of human colon.
Subjects and methods
Biopsies were obtained from 5 patients, M: F = 1: 4, with a median age of 58
(range 35-74) years. Patients had normal colonic mucosa at colonoscopy for
non-inflammatory conditions such as irritable bowel syndrome or during
colorectal cancer screening.
Biopsies, ~2 mm in size were collected from sigmoid colon with informed consent
from each subject who underwent colonoscopy for diagnosis of abdominal
complaints or for cancer screening. All patients were fasted from midnight as
required for colonoscopy on the following morning.
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Culture medium
The culture medium (100 ml) was Weymouth's MB752/1, 77 ml (ICN, UK.
Catalogue No. 252254), supplemented with 10 ml of 10 % foetal calf serum (ICN,
UK. Catalogue No. 2910154), L-glutamine 200 mM, 1.5 ml (Sigma, UK.
Catalogue No. G-7513), ascorbic acid 300 pg/ml, 10 ml (Sigma, UK. Catalogue
No. A-4544), ferrous sulphate 0.45 pg/ml, 20 pi (Sigma, UK. Catalogue No.F-
8633), penicillin 5000 i.u /ml and streptomycin 5000 pg/ml, 1 ml (Sigma, UK.
Catalogue No.P-4458), and gentamicin 50pg/ml, 0.5 ml (Sigma, UK. Catalogue
No. G- 1272). To each ml of complete medium 10 pi of bromodeoxyuridine (conc.
200 pM) was added for labelling proliferating crypt cells (Sigma, UK. Catalogue
No. B-5002).
Lipopolysaccharide-containing medium was constituted by the inclusion in
complete medium of 50-pg/ml lipopolysaccharide of Escherichia coli 055:B5
(Sigma, UK. Catalogue No. L- 2880). The biopsies were cultured in parallel and
under identical conditions (200) in the presence or absence of LPS.
Culture procedure
Immediately after removal, biopsies were transported to the laboratory which is
close to the endoscopy suite. The transport was done in complete medium, pre-
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gassed with 95% 02 and 5% C02 at 37 °C and the tissues were established in
organ culture within 10 minutes after biopsy. Biopsies were washed twice in
warm media. Under the dissecting microscope, biopsies were oriented, luminal
surface up, on Millipore filters (pore size 0.45 pm, diameter 25 pm, Millipore
Corporation, Bedford, MA, USA. Catalogue No. HAWP 02500). Filters were
placed on the rim of the organ culture dishes 5.5 cm in diameter with a central 2
cm well containing 1 ml of complete medium (Becton Dickinson UK Ltd.). The
central well is surrounded by an outer well into which 1 ml of 0.9% NaCI solution
was added. The dishes were covered, placed on a plastic tray and sealed in a
Plexiglas modular chamber [Bilups-Rothenburg™, California, USA], The modular
chamber was gassed with a mixture of 95% oxygen and 5% carbon-dioxide for 5
min at 5L/min, then sealed and maintained at 37°C in an incubator.
Histology technique
After 24 h of culture, explant tissues were rinsed and fixed by submerging in
Carnoy's fixative for 12-16 h followed by 99% industrial methylated sprit (IMS) for
another 12-16 h. Explant tissues were then processed to paraffin wax. Sections
of the entire width of the biopsy were then cut 5 pm thick with a microtome
(LEICA 2045 Multicut, Nussloch, Germany) and placed onto 0.1% poly-L-lysine
coated slides. The slides were coded.
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Electron microscopy of explant colon biopsies
Biopsies were fixed in 3% glutaraldehyde in 0.1 M cacodylate buffer (Sigma)
overnight at 4°C. Tissues were then washed in cacodylate buffer for 30 min and
post-fixed in 1% osmium tetroxide for 1 h in cacodylate buffer. Then tissues were
dehydrated through grades of alcohol 10% alcohol (3 changes, 10 min per
change), 50% alcohol (1 change 15 min), and 100% alcohol (3 changes 30 min
per change). Tissues were then dehydrated through propylene oxide (2 changes
20 min per change) and embedded in Araldite resin and polymerised in an
incubator at 56°C for 2-3 days. Thin sections (0.5-1 pm) were cut with a glass
knife and dried on a hot plate. The dried sections were stained with toluidine blue
in 1% borax for approximately 30 sec. Tissues processed for transmission
electron microscopy were chosen after observation of the thin sections by light
microscopy. Ultrathin sections were cut using a diamond knife, interference of
colours determined the section thickness (60-80 nm). The sections were placed
onto 300-mesh copper grids and allowed to dry for 30 min. and grids were
stained with uranyl acetate and lead citrate. The grids were examined in a JEOL
100 CX II transmission electron microscope (Tokyo, Japan) and photographs
were taken at 60 kV.
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Immunohistochemical staining for BrdU
Sections were de-waxed and placed in 1% hydrogen peroxide (H202) in
methanol for 20 min to block endogenous peroxidase. After washing in TRIS
buffered saline (TBS), pH 7.6, DNA was denatured by immersion of the slides in
1 N HCL for 8 min at 60°C to expose bound BrdU for immunostaining with a
streptavidin-biotin peroxidase technique. Tissue sections were incubated
successively in 20% rabbit serum in TBS for 10 min, 1:200 mouse anti-BrdU
(Becton-Dickinson, UK) for 60 min at room temperature, then 1:300 biotinylated
rabbit anti-mouse for 40 minutes, and finally in streptavidin/biotin- peroxidase
complex (ABC) for 30 min. After each step, sections were rinsed in TBS. Then
sections were incubated in 0.05 M TRIS/HCL buffer (pH 7.6) containing 0.05%
diaminobenzidine and 0.1% H202 for 10 min. Sections were counterstained with
haematoxylin, dehydrated through graded alcohol, cleared in Histoclear, and
mounted in synthetic resin. Sections were examined by light microscopy for
morphology of the tissue including epithelial cell shape and nuclear orientation,
oedema and crypt necrosis. The slides were coded and examined blinded.
Scoring of BrdU labelled cells
Four well-oriented tissue sections were examined from each biopsy and four
longitudinally sectioned crypts from each section were scored for BrdU labelling
under a light microscope at a magnification of x 400. Total numbers of cells, and
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the numbers and positions of BrdU-positive cells of each crypt were directly
keyed to a microcomputer for further analysis. The labelling index (LI) for each
crypt was determined from the percentage of BrdU positive cells out of the total
number of cells in that column. The total number of positive cells obtained for
each four crypts was used to calculate mean % LI values for each individual
biopsy.
Statistical analysis
Data were entered in a microcomputer and analysed in SPSSPC+ (SPSS PC+
Inc. Chicago, IL, USA). Continuous data were analysed by Mann-Whitney U -
test using a minimum probability of significance value of p < 0.05. Discontinuous
data were evaluated by Chi square analysis or Fisher's exact test.
Results
The histologic pictures of the colonic mucosa are shown after culture for 24 h in
control media, figure 5.1 or media containing LPS, figure 5.2. After culture in
control media, the morphology of the biopsy tissue was well preserved. The
epithelium was intact, cells were columnar in shape with basically oriented nuclei.
The crypts were regular with well -preserved cells, and in the upper part cells
were numerous and compact with slender nuclei. At the lateral margins of
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the cultured biopsy, areas of partial necrosis were noted. In these areas the
epithelium was lower and had cut surfaces. These areas were omitted on
histological judgement and morphometric analysis of biopsies. The biopsy
surface was covered by translucent mucus. Many mitoses were present in the
crypts, even after 24 h, as demonstrated by the incorporation of BrdU in the
dividing cells. All biopsies were examined in pairs from the same subject.
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Figure 5.1. Micrograph of bromodeoxyuridine labelled human
colonic crypt cells cultured in control media.
Scale bar = 20 pm.
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Figure 5.2. Micrograph of bromodeoxyuridine labelled human
colonic crypt cells cultured in LPS containing media.
Scale bar = 20 pm.
Histologic evaluation of the explant human colon biopsies from healthy subjects
illustrated that the cultured colon epithelium was intact after 24 h of culture in
complete medium (not incubated with LPS), with no apparent area of ulceration
or breach of epithelium. Parallel biopsies incubated with 50 pg of LPS per ml in
complete medium appeared indistinguishable from non-LPS treated cultured
biopsies.
The numbers of BrdU labelled cells were 2-5 per hemicrypt and a total of 75
labelled cells in control biopsies. In LPS-treated tissues, BrdU-labelled cells
ranged from 2-6 per hemicrypt and the total number of labelled cells was 73.
Mean (SEM) labelling indices (LI) in biopsies were not significantly different
between groups; 17(0.7) vs. 18(18), p = 0.3.
Transmission electron microscopy confirmed the impression gained by light
microscopy. The morphology of the epithelium was well maintained during in vitro
culture. Epithelial cells appeared to maintain integrity with neighbouring cells.
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Figure 5.3. Electron micrograph showing human colon epithelium
with intact tight junctions (cultured in LPS containing media).
Figure 5.4. Electron micrograph showing goblet cells filled with mucus
and organised with surrounding epithelial cells (cultured in
LPS containing media). Scale bar = 7.5 p.m
Colonic epithelium in LPS-treated biopsies appeared indistinguishable from
control biopsies. Their cytoplasm was compact, and the cytoplasmic organelles,
including mitochondria, elements of endoplasmic reticulum, Golgi material and
lysosomes were normal in appearance and distribution. The apical surfaces and
basal lamina were structurally intact as evident by intact tight junctions [Figure
5.3],
Goblet cells in the crypts were filled with large mucous granules and appeared
normal morphologically when viewed with electron microscope [Figure 5.4],
Discussion
Good morphological preservation of the tissue with intact epithelium after 24 h of
culture was observed in the explant human colon tissues in the present study.
Similar findings have been reported in organ culture of intestinal biopsies in man
and other species (199,201,202). It has been reported that after culture for 48
hours, tissue morphology is not so well preserved as cell proliferation and
synthetic function deteriorates after 24 hours of culture.
In the present study, human colon biopsies were cultured for 24 h and
morphology of the explant tissues has been well maintained as evident by light
and electron microscopy. No morphological changes were observed in
endotoxin-treated organ culture of human colon mucosa. This finding
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corroborates the findings of other investigators on the effects of LPS on
morphology of the intestinal epithelium.
There are very few reported studies on the effects of lipopolysaccharide on
cultured human intestinal tissues. In organ cultures of rabbit jejunal biopsies, it
has been observed that lipopolysaccharide at a concentration of 100 pg/ml
affects the morphology of the epithelial cells in the intestine (237). Walker et at.
reported that LPS at a higher concentration damages the integrity of the tissues
and disrupts tight junctions of the epithelial cells causing paracellular leakage
(238).
The stimulatory effect of lipopolysaccharide has been well established in animal
models, particularly to study the secretory activity in relation to the transport of
solutes and ions. LPS of E.coli at a concentration of 50pg/ml has been shown to
induce secretion of cytokines e.g., IL-1 at detectable levels in cultured human
intestinal tissues (225). At this dose the morphology of the tissues was not
affected during treatment of the tissues with 50p.g/ml of LPS. The dose of LPS in
the present study was adopted from the above-mentioned experimental study. In
the present study, it has also been observed that at a dose of 50 pg/ml of LPS of
E.coli the morphology of the cultured human intestinal tissues was unaffected
i.e., intercellular tight junctions remained intact, activity of goblet cells was
preserved as evident by presence of mucus within the cells, and subcellular
organelles remained intact.
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CHAPTER 6: QUANTITATION OF INORGANIC MICROPARTICLE-LADEN
MACROPHAGES IN THE HUMAN INTESTINE
Introduction
Non-degradabie microparticles have been reported in the human intestinal wall
and implicated as a probable cause of chronic inflammation in inflammatory
bowel disease (17,182). The possible source of microparticles is considered to
be dietary in food preservatives and in preparations used as adjuvant in
pharmaceutical products. In a recent clinical trial, a microparticle-free diet has
been found to improve the symptoms in Crohn's disease (96). It is now
considered that environmental microparticles present in the intestine may have a
role in the pathogenesis of IBD (18).
The aetiology of inflammatory bowel disease (IBD) typed as Crohn's disease and
ulcerative colitis is unknown. Both environmental factors and genetic
susceptibility have been implicated in the pathogenesis of IBD (226) but
environmental factors that may initiate the development of IBD are unknown.
Genetic knock out animal models deficient in IL-10 and IL-2 develop forms of
enterocolitis, but not in germ-free environments (171,227). Accordingly, studies
to find a possible microbial cause of IBD have been intensified over the last two
decades. Mycobacteria have received special attention (131-135). The possible
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role of measles virus has been vigorously postulated (141-143). To date, the
evidence for the role of any specific pathogen in IBD is inconclusive. Accordingly,
the search has been widened to discover any other agent that may initiate and
/or perpetuate inflammation in IBD. In the early days of the description of IBD, it
was considered that dietary non-degradable components might be responsible
for inflammatory bowel disease (145), and it is widely held that environmental
factors probably contribute to the process of inflammation in IBD, particularly in
Crohn's disease (18).
In the inflamed intestine of Crohn's disease and ulcerative colitis there is an
increase in the number of inflammatory cells, and the increased numbers of
macrophages in Crohn's disease are well documented (122-126). An increase in
the recruitment of peripheral blood monocytes in the intestinal mucosa has been
reported in IBD (228,229) and it has been recently noted that newly recruited
macrophages can be located in the gut mucosa even before Crohn's disease has
fully developed (230). In chronic inflammatory bowel disease the macrophages
are located sub-epithelially and are considered as resident macrophages
(100,228,229,231).
Shepherd (1987) first described inorganic microparticles in the human intestine
(181). Although analytical studies on the composition of the microparticles were
extensive, the cells that contain the microparticles were relatively ignored (182).
Inorganic microparticles have been reported in non-inflamed intestinal tissue but
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without quantitative data it is impossible to assess the role of microparticle-laden
macrophages in the inflamed intestine. It therefore seems important to study
more extensively macrophages that contain microparticles in the inflamed
intestine, with special reference to Crohn's disease and ulcerative colitis. The
aims of the present study were (1) to quantify microparticle-laden macrophages
in the human intestine by image analysis, (2) to compare microparticle-laden
macrophages from subjects with Crohn's disease, ulcerative colitis and normal
controls, (3) to determine the proportion of the area occupied by microparticle-
laden macrophages in Crohn's disease, ulcerative colitis and control subjects,
and (4) to identify the types of microparticles present in the human intestinal wall.
Materials and Methods
Subjects
Paraffin-embedded sections from 15 surgically resected intestines were
examined in this study. The patients consisted of three groups, Crohn's disease
(n=5), ulcerative colitis (n=5) and controls (n=5). Control subjects had surgical
resections from operations undertaken for colon cancer. Unaffected intestine was
selected to act as control tissue. Clinical and demographic data of the cases
have been presented in tables 6.1a, 6.1b and 6.1c.
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In Crohn's disease and ulcerative colitis cases, macroscopically evident areas of
small bowel/colon involved by perforation, fistula, thickening , or with any
polypoid lesion were excluded from sampling. Macroscopically normal areas near
the proximal or distal ends of the specimens were sampled. Tissue histology was
studied in H&E stained sections from the samples which showed infiltration of
inflammatory cells and indicated activity of the disease.
Control sections were free of polymorph infiltrates, significant lymphoid or plasma
cell infiltrates, oedema, fibrosis, regenerative epithelium or crypt destruction.
Three 5-pm sections were cut from each block. One was lightly stained with
haematoxylin and eosin (H & E) and the other two were prepared for
immunohistochemistry. All slides were coded and examined blinded.
Immunostaining for CD68 (Tissue macrophage)
Paraffin-embedded sections were de-paraffinized in Histoclear and graded
alcohols. Antigens were unmasked at high temperature (microwave at 800W for
20 min in citrate buffer). Tissue endogenous peroxidase activity was blocked with
1% hydrogen peroxide (H202) in methanol, washed and rehydrated in 0.05 M
Tris-buffered saline (TBS), pH 7.6. Then sections were incubated with 20%
filtered rabbit serum (Sappu) in TBS for 10 min prior to incubation with primary
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antibody, mouse monoclonal anti-human CD68, (1:40) (PG-M1, Dako, UK,
Catalogue No. M0876) for 60 min. Then sections were rinsed and washed in TBS
and incubated in rabbit anti-mouse biotinylated immunoglobulin (1:300, Dako,
UK, Catalogue No. E0413) for 60 min. Sections were re-washed, incubated in
streptavidin/biotin-peroxidase (ABC, Dako, UK, Catalogue No. K377-B) for 50
min. After washing in TBS, sections were incubated in 0.05%, 3,3' -
diaminobenzidine and 0.01% H202 in 0.05 M TBS (pH 7.6). Sections were
counterstained with 0.01% methyl green for easy detection of light brown stained
CD68+ cells (tissue macrophages) for image analysis. Serial sections from
surgically obtained tonsils were prepared as positive controls and sections
stained without the primary antibody were used as a negative control (232).
Serial sections were also immunostained by streptavidin/biotin-alkaline
phosphatase method. In brief, in the third step of immunostaining
streptavidin/biotin-alkaline phosphatase (ABC, Dako, Catalogue No. K391) was
used instead of streptavidin/biotin-peroxidase at a dilution of 1:300. After washing
in TBS, sections were incubated with New fuchsin substrate system (Dako, UK,
Catalogue No. K698) and sections were counterstained with Harris hematoxylin.
Highly chromogenic bright reaction products help to detect blue stained nuclei
and black microparticles on a pink-red background, and facilitates enumeration of
CD68+ cells with or without microparticles in the tissues (233).
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Image analysis of macrophages (CD 68+ cells)
Measurement of CD68+ve area
Immunostained sections were initialised at magnification 400 and calibrated for
measurements in square microns (pm2). After initialisation, a dark brown colour
as indicator of CD68 positive cells was detected and confirmed with the colour
intensity throughout the field; then areas of positive cells in consecutive 25
frames (13014 pm2) per tissue were measured by an in-built automatic colour
detection system. Results were expressed as total tissue area, area occupied by
CD68 positive cells in the tissues in square microns, and also as the proportion
of CD68 positive area to the total tissue area.
Count of CD68+ve cells
Macrophages were counted by image analysis (LEICA, Germany). In brief,
immunostained sections were initialised at magnification 400 and calibrated in
square microns as before and in 25 consecutive frames CD 68+ cells were
analysed. First, all CD68+ve cells in a field were marked and confirmed with
colour detection, and subsequently marked cells were counted automatically by a
Leica in-built program. In the second step, immunostained microparticle-laden
cells (that appear as black dots on a pink-red background) were marked and
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automatically counted as before. CD68 positive cells not loaded with
microparticles were derived from the two counts. The number of CD68+ve cells,
with or without particles were expressed as total number per mm2 of tissue and
as a proportion of the total cells.
Confocal microscopy
The locations of inorganic microparticle-laden in the tissues were noted and were
investigated by confocal laser scanning microscopy (CLSM, Carl-Zeiss,
Germany). The cells were initially identified under CLSM with transmitted light
using differential interference contrast optics, x 63 objective and x 40 to 160
zoom. Later an argon ion laser with helium neon of 633 nm wavelength was used
to obtain confocal images of a cell at an interval of 1 pm and photographed. The
inorganic microparticles, unlike tissue, reflect the laser light and become visible in
the surrounding non-reflecting area of the nucleus.
X-ray microanalysis
An area of tissue was selected using H & E section and a piece of tissue was
removed from this area in the paraffin blocks of resected intestine using a single
edged razor blade. The tissue was placed in chloroform for 2 x 2 hours to remove
the wax. The chloroform was removed by washing the specimen in 740P sprit 3 x
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1 h. Whilst in alcohol the specimen was trimmed or sliced into smaller pieces to
aid penetration of the resin. The specimen pieces were then infiltrated with 50:50
LEMIX epoxy resin (TAAB, Birkshire, UK), 740P spirit, overnight. The following
morning the specimen was placed in 100 LEMIX resin for 8 hours. Individual
pieces of tissue were then embeded in fresh resin and polymerised at 70°C
overnight. One micron semi-thin sections were cut using a glass knife on a
Reichert Ultracut ultramicrotome (Leica, UK) and stained, on a 90°C hot plate,
aniline blue/azure II for 10 mins followed by 0.01% basic fuchsin for 40 seconds
and reviewed under a light microscope. The microparticles were clearly visible
within the cytoplasm of the macrophages in an area of section subsequently
subjected to X-ray microanalysis. Then 100 pm ultrathin sections were cut using
a diamond knife and mounted on Pioform (Agar Scientific, UK) coated grids. One
section was stained with saturated uranyl acetate in 50% ethanol, followed by
Reynold's lead citrate and rest were left unstained for EDAX.
Then unstained sections were viewed under a transmission electron microscope
(Philips CM 120, Holland). Microparticles were identified within vesicles in the
cytoplasm of the cells and microanalysis was performed using an EDAX (Energy
dispersive analysis of X-rays) DX4 attached to the microscope with a transmitted
electron detector at magnifications of 10,000 and above. This technique yields
information on all elements present within a tissue with an atomic weight greater
than that of sodium (atomic weight 22). The analysis conditions were 80kV, 60nm
spot size. A detailed description of the technique has been made in the Methods
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section (Chapter 3). Briefly, the spectrum of an element was analysed by DX4
that matches the standard spectrum of the element in the database.
Statistics
The mean of a series of observations from a case was taken to represent the
value for that observation and was included in the final analysis. Descriptive
statistics included mean and standard error of the mean. Values from specific
subgroups of patients were then compared using t-test. A probability of value of
<0.05 was considered as significant.
The number of macrophages is the mean of observations for a case in this
analysis. Similarly, microparticle-laden macrophages, proportion of microparticle-
laden macrophages, macrophage area, and proportion of macrophage area to
the tissue area measured (as a percentage) is the mean of the observations from
a single case. The values have been included in the final analysis for comparison
between groups. The mean and standard error of the mean of the parameters
have been presented and comparison between groups was done using t-test. A
probability of value of <0.05 was considered as significant.
Data were entered in a personal computer and analysed in SPSS PC+. The




In lightly stained (H & E) sections, inorganic microparticles and cells that
contained microparticles were noted. By conventional light microscopy at
magnification 400, inorganic microparticles appear as dark black dots but are
difficult to detect below that magnification.
Immunostaining with CD68 antibody specific for tissue macrophages confirmed
that positively stained microparticle-laden cells in the resected tissues are
macrophages. The macrophages were located in the mucosa and submucosa of
the intestinal tissues. Microparticle-laden macrophages were identified
immediately beneath the epithelium in the lamina propria of IBD tissues [Figure
6.1]. Macrophages were also located in and around the Peyer's patches and
colonic lymphoid follicles.
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Image analysis
By image analysis the numbers of macrophages, and microparticle-laden
macrophages were determined. The average of observations from each case
was presented in table 6.2a. The numbers [Mean ± SEM] of macrophages were:
12 ± 1.7, 9.5 ±1.2 and 6.3 ± 1.2 in Crohn's disease, UC and control tissues
respectively. Similarly, the number inorganic microparticle-laden macrophages
were: 9.2 ± 2.4, 5.3 ±1.9 and <1 ±0.02 in Crohn's disease, UC and control tissues
respectively. The percentage [mean ± SEM] of microparticle-laden macrophages
was 69.9 ± 13.7 vs. 49.4 ± 15.3 vs. <1 ± 0.3 in Crohn's disease vs. ulcerative
colitis vs. controls (p < 0.01) [Table 6.2a], In one control tissue, microparticles
were located within a CD68 positive cell.
By image analysis macrophage area (pm2) was measured optically by detecting
area of the brown stained CD 68+ cells on a light green background [Figure 6.2],
The macrophage area (mean± SEM) was: 825± 201, 547± 65 and 312± 20 in
Crohn's disease, ulcerative colitis and control tissues respectively
(p=<0.01)[Table 6.2b], The percentage of macrophage area was [mean ± SE]:
6.3 ± 1.5, 4.2 ± 0.5 and 2.4 ± 0.16 in Crohn's disease, ulcerative colitis and
controls respectively [Table 6.2b]. The measured area was the same (25 x 13014
pm2) for all groups.
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Figure 6.1. Immunolabelled microparticle-laden macrophages
beneath the epithelium in a Crohn's tissue. Counter
stained with hematoxylin. Scale bar = 15 pm
Figure 6.2. Immunostained (CD68+) microparticle-laden macrophage
in a Crohn's section. Counterstained with 0.01% methyl green.
Scale bar = 15 pm
Both microparticle-laden macrophages [Figure 6.3] and microparticle-laden
macrophage area [Table 6.2b] were significantly increased in Crohn's disease
compared to ulcerative colitis and controls [p<0.01].
1macro Kl"acro+ Wacro-
□Crohn's BUC □Control
Figure 6. 3 Macrophage (CD68+) count/mm2 in resected intestine of patients
with Crohn's disease, UC and control. Tmacro = Total number of
macrophages; Macro+ = microparticle-laden macrophages; Macro-
= macrophages not containing microparticles.
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Figure 6.4. Confocal micrograph showing inorganic microparticles
reflecting laser light and visible in the surrounding
non-reflecting area including nucleus. Scale bar = 25 pm
Figure 6.5. X-ray micrograph of microparticles in Crohn's intestine.
Yellow = titanium; Green = aluminium; Blue = silicon
Scale bar = 1 pm
Confocal and electron microscopy
Using Confocal laser scanning microscopy microparticles were located in
clusters within the macrophages in the mucosa [Figure 6.4], Thin sections
stained with aniline blue/azure II and basic fuchsin confirmed this finding. By
transmission electron microscopy, sub-micron size particles were observed
packed within membrane vesicles that had the appearance of phagolysosomes.
X-ray microanalysis
By X-ray microanalysis in association with transmission electron microscopy sub-
micron size particles were determined as compounds of silicon, titanium,
aluminium and chromium [Figure 6.5]. The compounds of chromium have not
been reported before in human intestinal tissues. Figure 6.6 shows the X-ray
spectrum in an area with electron dense microparticles of chromium (the copper
and nickel peaks are from the grids). One of the double peaks is an "escape
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In the present study, chromium has been detected for the first time in human
intestinal mucosa. Chromium is a hard, steel-grey brittle metal with a molecular
weight of 52. It is found as chromite, a mixed chromium-iron oxide, which occurs
as a dark-brown or black mineral. Local exposure to chromium particles has
been reported to cause ulceration of the skin and mucus membrane (234).
Experimental rats exposed to chromium particles have been shown to develop
chronic interstitial inflammation in the alveolar septa, characterised by infiltration
of inflammatory cells including macrophages (235). There are no reports of
inflammatory reactions to chromium in the intestinal tissues of experimental
animals. Although in two cases chromium was found in human intestinal
macrophages in the present study, the finding cannot be correlated to with any
clinical features or complications, as in other cases with similar complications
chromium was not identified. However, it is possible that chromium may cause
damage to the intestinal tissues as in lung tissues and this needs to be explored
in a larger number of cases.
To identify the possible source of chromium, Ministry of Agriculture, Food and
Fisheries (MAFF) was contacted: it appears that vitamin preparations and
mineral supplements contain chromium. On checking (in various food stores) it
was advised that vitamins and mineral supplements for human consumption e.g.
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Centrum, Multibionta, contain chromium. This is a possible source of the
chromium particles that have been identified in resected specimens in this study.
So far there is only one published report (182) on X-ray microanalysis of human
intestinal tissues with inorganic particles. In this thesis a second report on X-ray
microanalysis of human intestinal tissues has been presented, and chromium
has been identified for the first time in Crohn's disease affected intestine.
In the present study inorganic microparticles were clearly observed within the
macrophages in the lamina propria of the intestine in Crohn's disease and
ulcerative colitis. This finding confirms a previous report of inorganic
microparticles in inflamed human intestine (182). It had been reported that
inorganic microparticles were present only in the basal part of the Peyer's
patches and colonic lymphoid follicles of the human intestine but, in the present
study, inorganic microparticles were observed immediately beneath the
epithelium in the mucosa and also in the submucosa, in addition to their
presence around the gut associated lymphoid tissues. Studies on inorganic
microparticles in human intestine have previously focussed on the elemental
analysis of the microparticles. The present study of inorganic microparticle-laden
macrophages in human intestinal cells has considered the extent of their
involvement in IBD. In the present study, a specific marker (CD68) was used that
identifies tissue macrophages and by image analysis it has been conclusively
shown that inorganic microparticle-laden macrophages are significantly
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increased in Crohn's disease compared to UC and controls. Specifically, the
proportion of the area occupied by microparticle-laden cells was found to be
significantly increased in IBD compared to non-inflamed control tissues. A
quantitative analytical study of inorganic microparticle-laden macrophages in
inflamed human intestine has not been reported to date.
Inorganic microparticles as compounds of titanium, silicon and aluminosilicate
were documented in phagosomes of the macrophages in the present study.
These findings support previous reports on the intracellular location of inorganic
microparticles (17,128). The source of these microparticles is presently unknown.
Many pharmaceutical preparations contain titanium, and compounds of
aluminium and silicate are widely used in the food industry in preservative
preparations. It is likely that the microparticles that have been found in the
present study and by others in resected human intestine were ingested and
subsequently translocated into intestinal mucosa.
An increase in the number of macrophages in the mucosa has been reported in
the early stages of inflammation of Crohn's disease (230) and these cells have
been shown to be newly recruited peripheral monocytes because of their
expression of CD 14+L1, which are not expressed by resident macrophages
(99,230,236). The stimulus for the recruitment of macrophages into tissues of the
intestine is not known. However, luminal factors such as lipopolysaccharide of
the resident gram-negative bacteria or any inflammatory pathology already
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present in the intestine may have some role in the uptake of inorganic
microparticles by the intestinal mucosa. It is possible that the presence of
inorganic microparticles conjugated with LPS may stimulate the recruitment of
macrophages from the peripheral blood.
The fate of macrophages that have phagocytosed inorganic microparticles is
unknown. Inorganic microparticles conjugated with LPS have been shown to
increase secretion of proinflammatory cytokines e.g., IL-1 p in human intestinal
macrophages (121). Macrophages play a significant role in removing apoptotic T
cells, which are increased in inflammatory bowel disease. Studies have shown a
decreased phagocytic capacity of macrophages to engulf apoptotic cells is other
diseases (237). It is possible that engulfed inorganic microparticles may cause
dysfunction of macrophages in efficient removal of the apoptotic cells that may
be involved in the perpetuation of the inflammatory process in IBD. The observed
benefit of a low inorganic microparticle-containing diet in Crohn's disease
supports this view (96).
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CHAPTER 7: LIPOPOLYSCCAHRIDE INCREASES UPTAKE OF
MICROPARTICLES IN INFLAMED HUMAN COLON MUCOSA IN VITRO
Introduction
In animal studies, uptake and translocation of 2-pm-size polystyrene
microparticles have been demonstrated in the small intestine in vivo (48). In the
earlier studies, it had been observed that microparticles in the nanometre to
micron range were taken up by the gastrointestinal mucosa (238,239) and it was
believed that smaller (< 1pm) microparticles could only be transported across the
intestinal mucosa. Most studies related to the uptake of microparticles have been
done from the point of view of a drug or vaccine delivery (240). However,
transcytosis of such microparticles may have pathological implications (241). The
exact mechanisms and pathways of microparticle transport are not totally clear
(242). Three possible pathways of microparticle uptake across gut mucosa are:
(i) transcellular(48); (ii) through specialised M-cells (243); and (iii) paracellular
(67,79). Most of the microparticle uptake studies have been done in animals and
are limited to the small intestine (244). Studies on the uptake of polystyrene (or
similar) microparticles with human tissues are non-existent, and for ethical
reasons will not be possible in the foreseeable future. It is generally believed that
the colon is impermeable to microparticles, and there is a lack of data on the
uptake of microparticles by human colon mucosa (241).
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The colon hosts a number of bacteria and one of their products,
lipopolysaccharide (LPS) has been shown to alter epithelial cell metabolism
and/or damage the mucosal barrier (245-247). In animal studies, it has been
observed that if bacterial cell wall products such as LPS traverse the intestinal
epithelial barrier, a chronic granulomatous inflammatory condition resembling
Crohn's disease may develop (248). Increased transmucosal transport of
macromolecules has been observed in inflamed human colonic mucosa in vitro
(249) and this has been suggested as secondary to the action of bacterial toxin
(250). However, there is no experimental evidence of the effect of LPS on the
uptake of microparticles in healthy or inflamed human colonic mucosa.
The aim of this study was to (i) demonstrate whether transport of micron-size
particles occurs across colon mucosa in vitro and (ii) determine the effect of LPS
on the uptake of microparticles, in non-inflamed colonic mucosa from normal
subjects and inflamed mucosa from patients suffering from IBD.
Materials and Methods
Subjects
Four biopsies from the sigmoid colon were taken, with informed consent, from
ten fasting patients undergoing colonoscopy either for diagnosis or for cancer
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screening. All patients were fasted from midnight as required for colonscopy on
the following morning. The Medicine and Oncology Subcommittee of the Lothian
Ethics in Research Committee approved this study.
Culture medium
The culture medium was Weymouth's MB752/1 (ICN, UK. Catalogue No.
252254), supplemented with 10 % foetal calf serum (ICN, UK. Catalogue No.
2910154), L-glutamine 200 mM 1.5 ml (Sigma, UK. Catalogue No. G-7513),
ascorbic acid 300 pg/ml (Sigma, UK. Catalogue No. A-4544), ferrous sulphate
0.45 pg/ml (Sigma, UK. Catalogue No.F-8633), penicillin 5000 i.u. /ml,
streptomycin 5000 pg/ml (Sigma, UK. Catalogue No.P-4458), and gentamicin
50pg/ml (Sigma, UK. Catalogue No. G- 1272).
Culture procedure
Colonoscopic biopsies were obtained between 9 and 11 am to exclude any
theoretical effects of diurnal variation. Immediately after removal, biopsies were
transported promptly to the laboratory, which is close to the endoscopy suite. The
transport was done in complete medium, pre-gassed with 95% 02 and 5% C02 at
37 °C and the tissues were established in organ culture within 10 minutes after
biopsy. Biopsies were washed twice in warm media. Under the dissecting
microscope (Watson, Barnet, England) biopsies were oriented, luminal surface
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up, on Millipore filters (pore size 0.45 pm, diameter 25 pm, Millipore Corporation,
Bedford, MA, USA. Catalogue No. HAWP 02500). The filters were then placed
on the rims of organ culture dishes. Sterile plastic organ culture dishes (Falcon,
Becton Dickinson UK Ltd. Cat. # 3037) 5.5 cm in diameter were used, with a
central 2 cm well into which 1 ml medium was placed. The central well is
surrounded by an outer well in which 1 ml of 0.9% NaCI solution was added. The
dishes were covered, placed on a plastic tray and sealed in a Plexiglas modular
chamber [Bilups-Rothenburg™, California, USA], The modular chamber was
gassed with a mixture of 95% 02 and 5% C02 for 4 min at 5L/min, then sealed
and maintained at 37°C in an incubator.
Biopsies were cultured in (i) complete medium with bromodeoxyuridine (BrdU);
(ii) complete medium with microparticles; (iii) complete medium with LPS and
microparticles; and (iv) complete medium with BrdU and LPS. The biopsies were
cultured in parallel and under identical conditions (200).
The organ culture technique that has been used in this study is essentially that
described by Prichett et al (251). Monoclonal antibody against the thymidine
analogue BrdU permits identification of cells in S-phase of mitosis by an
immunohistochemical technique (206). Retention of normal morphology of the
tissue and incorporation of BrdU in DNA of dividing cells were considered as
indices of the survival of explant tissues (196). In these experiments 10 pi of
150
BrdU (200 mM, Sigma, UK. Catalogue No. B-5002) was added to each ml of
complete medium.
Lipopolysacharide
Lipopolysaccharide (LPS) of Escherichia coli 055:B5 (Sigma, UK. Catalogue No.
L- 2880) 50 pg / ml was added to the test culture media at 0 hour to study the
effect of endotoxin on microparticle transport. In vitro studies have demonstrated
that this concentration of the LPS of E.coii liberated cytokines and growth factors
without altering morphology of the intestinal mucosa (225,252).
Microparticles
To study microparticle uptake and translocation, plain (non-ionic), mono-
disperse, yellow-green (Y-G) fluorescent polystyrene latex microparticles (2.5 %
solid content, 2.0 pm in diameter) with Y-G dye excitation (Polysciences Inc.,
Warrington, USA. Catalogue No. 18338) and with emission minimum and
maximum of 545 and 610 nm, respectively, were used. The stock suspension
was diluted in sterile de-ionised water to obtain a microparticle concentration of
5.68 X 106 per 0.1 ml. After 3 hours of incubation, 50 pi of microparticle
suspension was added to the explant tissues. Explant tissues were cultured at
37°C for a further 21 h.
151
To test viability after 24 h of culture, explant tissues were rinsed and fixed by
submerging in Carnoy's fixative for 12-16 h followed by 99% industrial
methylated sprit (IMS) for another 24 h. Explant tissues were then processed to
paraffin wax. Sections of the entire width of the biopsy were then cut at 5 pm with
a microtome (LEICA 2045 Multicut, Nussloch, Germany) and placed onto 0.1%
poly-L-lysine coated slides for subsequent immunostaining. The slides were
coded.
Confocal laser scanning microscopy
Of the numerous methods for evaluating uptake and translocation of
microparticles, two techniques are well established: quantification of particulates
in bulk macerated specimens and in situ visualisation (253). Each of these
methods has advantages and limitations. The major weakness of the maceration
technique is lack of information provided at cellular level and particularly so in
gastrointestinal tissues where even after thorough washing, maceration makes it
impossible to decide whether microparticles were originally within the mucosa or
were merely overlying the mucosal surface. In this study therefore, the second
method was adopted.
Explant tissues (incubated with polystyrene microparticles) were coded and
mounted in Cryo-M-Bed embedding compound (OCT) and frozen at -52°C (Bright
Cryospray 134) and stored at -70°C until cryosections were made. Thirty 15-pm-
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thick cryosections (Bright's Hacker cryostat, UK) from each explant tissue were
taken on poly-L-lysine-coated glass slides and dried at room temperature (22°
C).
The uptake of microparticles into the mucosa was assessed in propidium iodide
(Sigma, UK. Catalogue No. P-4170) stained cryosections. Briefly, cryosections
were incubated in 0.001 mg/ml of propidium iodide in 0.1 M sodium cacodylate
buffer for 30 min and mounted without dehydration, in fluorescence mounting
medium (DAKO, UK. Catalogue No. S-3023). Particle distribution across mucosal
sites was analysed by epifluorescence microscopy. The first 10 good quality i.e.,
not fragmented, 15 pm sections were used from a pool of 30, giving a total
thickness of 150 pm of tissue sampled from each biopsy.
The localisation of the fluorescent microparticles within tissue compartments was
determined using a confocal laser scanning microscope (LSM; LEICA TCS NT,
Leica Microsystems, Mannheim, Germany) with an argon ion laser. At first, the
LSM with filters for FITC and TRITC excitation was adjusted. The lateral and
basal one-fourths of the sections were excluded from the analysis because of the
cut during biopsy. After targeting the area to be counted, optical sectioning (1
pm) by argon laser was employed to locate microparticles within the mucosa.
Fluorescent microparticles were marked and counted automatically by the
UHTHA Image tool program and measurement of tissue area were done by
marking the area using the same software (The University of Texas Health
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Science Centre, San Antonio, USA). Counts and measurements were done by
two observers with 83% agreement (k = 1).
Immunostaining for BrdU
Sections were de-waxed and placed in 1% hydrogen peroxide (H202) in
methanol for 20 min to block endogenous peroxidase. After washing in 0.05 M
TRIS buffered saline (TBS), pH 7.6, DNA was denatured by immersion of the
slides in 1 N HCL for 8 min at 60°C to expose bound BrdU for immunostaining
with a streptavidin-biotin peroxidase technique. Sections were incubated
successively in filtered rabbit serum in TBS (1:4, NRS/TBS) for 10 min, in mouse
monoclonal anti-BrdU antibody (Becton-Dickinson, UK) in NRS/TBS (1:200) for
60 min, in biotinylated rabbit anti-mouse immunoglobulin in NRS/TBS (1:300) for
40 minutes, and finally in streptavidin/biotin-peroxidase (ABS, Dako, UK) for 30
min. at room temperature. After each step, sections were rinsed in TBS. Then
sections were incubated in 0.05 M TRIS/HCL buffer (pH 7.6) containing 0.05%
diaminobenzidine and 0.01% H202 for 10 min. Sections were counterstained with
Harris hematoxylin, dehydrated through graded alcohol, cleared in histoclear,
and mounted in synthetic resin.
BrdU-stained sections in each experiment were systematically reviewed for crypt
architecture, epithelial cell shape, and nuclear orientation, oedema and cell
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debris in the lamina propria, crypt necrosis, and amorphous material surrounding
the crypts.
Electron microscopy
To confirm the location of microparticles within the cytoplasm of cells, 1 mm
cubed pieces of tissue were fixed overnight at 4°C in 3% glutaraldehyde in 0.1 M
sodium cacodylate buffer. Tissues were then washed in cacodylate buffer for 30
min and post-fixed in 1% osmium tetroxide (1h) in cacodylate buffer; dehydrated
through various grades of alcohol, 10% (3 changes 10 min per change), 50%
alcohol (1 change 15 min), 100% alcohol (3 changes 30 min per change). Then
dehydrated through propylene oxide (2 changes 20 min per change) and
embedded in Araldite resin and polymerised in a 56°C incubator for 2-3 days.
Thin sections (0.5 - 1 pm) were cut with a glass knife and dried on a hot plate.
The dried sections were stained with toluidine blue in 1% borax for approximately
30 sec. The sections were examined under light microscope and areas with
microparticles were selected. Ultra thin sections were cut using a diamond knife;
interference colours determined section thickness (60-80 nm). The sections were
placed on copper grids (mesh size 300) and allowed to dry for 30 min. The grids
were stained with uranyl acetate and lead citrate. The grids were viewed in a
JEOL 100CXII-transmission electron microscope (Tokyo, Japan) and
photographs were taken at 60 kV.
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Statistical analysis
Data were entered in a personal computer and analysed in SPSSPC+ (SPSS
PC+ Inc. Chicago, IL, USA).
The mean of a series of observations from a case was taken to represent the
value for that observation and was included in the final analysis. Values from
specific subgroups of patients were then compared using t-test. Descriptive
statistics included mean and standard error of the mean (SEM).
The value for uptake of fluorescent polystyrene microparticles (microparticle
count/mm2) were compared by using t-test. A probability (p) value of < 0.05 was
considered as significant. The mean of observations from a case was included in
the final analysis.
Results
Biopsies (~2mm) were obtained from ten patients, four men and six women with
a median age of 47 years (range 30 - 66 years). Clinical and demographic data
of patients with Crohn's disease and ulcerative colitis has been presented in
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Table 7.1.Three patients had established colonic Crohn's Disease and two had
ulcerative colitis.
For Crohn's and ulcerative colitis biopsies, areas of intestine were assessed for
the disease states by an experienced colonoscopist. Biopsies were collected
from areas appearing endoscopically normal or mildly inflamed (loss of vascular
pattern). Areas of severe inflammation with contact bleeding or severe disease
with friability, ulcers or spontaneous bleeding were excluded for biopsy (Gomes
et a!.). H & E stained sections of the biopsies were examined for the tissue
histology.
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Morphology and BrdU labelling
Morphology of the cultured colonic mucosa was well maintained in culture for 24
h. Many mitoses were present in the crypts, even after 24 h, as demonstrated by
the incorporation of BrdU in the dividing cells. Epithelium was intact and crypt
architecture was well maintained. Biopsies from normal controls cultured in
medium containing LPS were morphologically indistinguishable from the biopsies
cultured in control medium. Similarly, biopsies from IBD patients cultured in
medium containing LPS were indistinguishable from the biopsies cultured in
control medium. Figure 7.1 is light photomicrograph of a section from a IBD
patient cultured in control media, and 7.2, represents a similar section from an
inflamed tissue cultured in media containing LPS.
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Figure 7.1. Micrograph of IBD mucosa cultured in control media. BrdU
labelled cells appear as brown. Scale bar = 20 pm
Figure 7.2. Micrograph of IBD mucosa cultured in LPS containing media.
BrdU labelled cells appear as brown. Scale bar = 20 pm
Localisation and quantitation ofpolystyrene microparticles
Microparticles were located beneath the epithelium and in the lamina propria in
propidium iodide stained cryosections of cultured human colon mucosa
examined by the confocal laser-scanning microscopy (LSM). Fluorescent
microparticles were observed in the associated mucus along the mucosal surface
within colonocytes and goblet cells of the epithelium and lamina propria.
Microparticles were also located with cryptal epithelium and pericryptal stroma.
Serial optical sectioning (1 pM) by confocal microscopy clearly identified the
position of the fluorescent microparticles within the tissues and established that
their presence was not artefactual [Figure 7.3 and 7.4].
The mean numbers of fluorescent microparticles found within the cultured human
colonic biopsies differed between normal and IBD groups (Table 7.2). In normal
tissues, the numbers of fluorescent microparticles were similar irrespective of the
incubation with or without LPS. The numbers of microparticles were markedly
greater in IBD mucosa compared to normal mucosa. The numbers of fluorescent
microparticles were further increased in IBD mucosa when incubated with LPS
[Figure 7.5].
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Figure 7.3. Confocal micrograph showing 2 pm fluorescent microparticles
in IBD mucosa cultured in control media. Cryosections
stained with propidium iodide. Scale bar = 20 pm.
Figure 7.4. Confocal micrograph showing 2 pm fluorescent microparticles
in IBD mucosa cultured in LPS containing media. Cryosections
stained with propidium iodide. Scale bar = 20 pm.
Table 7. 2: Effect of lipopolysaccharide on transcytosis of fluorescent
polystyrene microparticles in explant human colon mucosa
Control Control +LPS IBD IBD+LPS
(N=5) (N=5) (N=5) (N=5)
Tissue area 2.83 2.78 2.78 2.82
(mm2)
Total count 81a CD 00 cr 211° 686d
fCount/mm2 28± 2.5e 36± 3.6f 77±21.79 245± 31.4h
Values are mean ±SEM; a vs. b, p = NS; a vs c and d, p<0.05; b vs c and d
p<0.05; c vs d p<0.01; e vs f, p=ns; e vs g, p=0.05; e vs h, p<0.01; f vs g, p=0.09;
f vs h, p<0.01; g vs h, p<0.01; t- test.
When IBD cases were dissected out to evaluate the effect of LPS, it appears that
in four cases (2 Crohn's and 2 UC) LPS increased the uptake of microparticles
(Figure 7.5 and Table 7.3). In one Crohn's cases there was minor increase
compared to others. When the cases were evaluated the uptake of microparticles
















Control Control + LPS IBD IBD + LPS
Figure 7. 5 Numbers of polystyrene microparticles/mm2 in control and IBD
subjects in presence of LPS. The values are mean of ten
observations from a case. N=5.
Table 7.3: Data on number of microparticles/mm2 in IBD patients
Patients Clinical
diagnosis IBD IBD+LPS
A Crohn's 40.5 278.7
B UC 69.1 311.7
C Crohn's 160.8 172.2
D Crohn's 70.0 165.6
E UC 45.7 296.0
MeaniSEM 77.2±21.7a 244.8±31.4b
Values are mean often observations from a case, a vs b, p<0.01; t-test.
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Electron microscopy
In transmission electron microscopic (TEM) studies, polystyrene microparticles
were observed within the epithelial cells of the human colon in vesicles [Figure
7.6]. In the lamina propria, microparticles were present within macrophages
[Figure 7.7], The TEM studies confirmed the impression gained with the light
microscopy that the epithelial morphology was well maintained during in vitro
culture of human colon biopsies for 24h. Colonocytes appeared to maintain
integrity with neighbouring cells as evident by intact tight junctions when the
biopsies were cultured in medium containing LPS. The cytoplasm was compact,
and the cytoplasmic organelles, including mitochondria, elements of endoplasmic
reticulum, golgi complex and lysosomes were normal in appearance and
distribution. The apical surfaces and basal lamina were structurally intact. The
goblet cells in the crypts were filled with large mucus granules and appeared
normal morphologically when viewed with the electron microscope. No
polystyrene microparticles were seen in intercellular junctions.
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Figure 7.6. Electron micrograph showing 2 pm polystyrene microparticle
within a colonocyte in LPS treated IBD tissue.
Scale bar = 2.25 pm
Figure 7.7. Electron micrograph showing 2 pm polystyrene microparticle
within a macrophage in LPS treated IBD tissue.
Scale bar = 2.25 pm
Discussion
Uptake and translocation of microparticles have been observed within the
intestinal mucosa in previous studies after intragastric administration of
polystyrene microparticle to rodents (20,48,253,254). In the present in vitro
model, for the first time, uptake and translocation of polystyrene microparticles by
human colonic epithelial cells have been demonstrated. Beneath the epithelium,
fluorescent microparticles were observed in the lamina propria. Serial optical
sections viewed by confocal laser scanning microscopy permit identification of
fluorescent microparticles within a tissue (255), but the intracellular location of
microparticles cannot be determined by this technique. By transmission electron
microscopy, microparticles were located within the epithelial cells and in the
macrophages in the present study. Uptake studies in animals by other
investigators also indicated that microparticles were located within the cytoplasm
of the epithelial cells and macrophages in vesicles (64,256). In this study,
microparticles were present in the epithelium and beneath the epithelium in the
lamina propria. The microparticles were attached to or in close proximity to the
apical surface of the colonocytes, and the observation of microparticles within the
cytoplasm of the colonocytes suggests that microparticles had entered through
the epithelium of the human colonic mucosa in this experimental model. The
observed presence of microparticles in vesicles suggests an endocytic uptake
mechanism (56,63,77,242).
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Microparticles were transcytosed in very small numbers by control colonic
mucosa and LPS did not increase the numbers.
It is established that there is increased infiltration of newly recruited
macrophages in the lamina propria of the inflamed intestine e.g., Crohn's disease
(228-230). This has also been observed in this thesis (Chapter - 6).
Lipopolysaccharide has been shown to liberate epidermal growth factors from
mucosal cells such as macrophage (265). Addition of epidermal growth factors
has been shown to increase uptake of microparticles (94). In the inflamed
intestine examined in the present study, this effect is more pronounced due to
the presence of increased number of macrophages and possibly would be less
marked in the non-inflamed intestine due to the smaller number of macrophages.
This is most likely the explanation for the lower uptake of microparticles by the
control (non-inflamed) tissues observed in this thesis.
The significance of the transport of small numbers of microparticles in health is
unknown. At least in vitro, healthy human colonic mucosa cannot completely
exclude the uptake of microparticles as large as 2-pm in diameter. In IBD
biopsies, greater numbers of microparticles were taken up compared to controls
and this may be due to mucosal inflammation and altered histology. However,
the significantly increased uptake of microparticles in the presence of LPS by the
inflamed mucosa is an important observation and appears to indicate a possible
effect of LPS on inflamed mucosa in IBD. LPS has been shown to liberate
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epidermal growth factors (EGF) from the mucosal cells such as macrophages,
fibroblasts and epithelial cells (252). EGF acts on EGF receptors (EGF-R) of the
epithelial cells and has been shown to stimulate increased macropinocytosis in
human epidermal cell culture studies (94). The molecular mechanism of
increased macropinocytosis is not totally clear but growth factor induces
membrane ruffling of the "edge end" of the cells and this appears to be regulated
by members of the ras family and particularly the rho sub-family of ras-related
GTPases. Increased macropinocytosis is the most likely explanation for the
increased uptake of microparticles in IBD biopsies in the present study.
Transport of microparticles as well as bacteria and viruses through M cells has
been documented in animal models (42,43,257). Flowever, transport by
transcellular (256) and paracellular routes has not been excluded in these
models. In this in vitro experiment with human colon biopsies, microparticles
were identified as inclusions within the cytoplasm of the colonocytes; the entry
appears to be transcellular and this is likely to be by macropinocytosis (94,258).
It has been suggested that microparticles may move through the epithelial barrier
in a paracellular way (54), but in our study we have not found any evidence for
this. The uptake and transcytosis of bacteria, 2-pm-size microparticles and yeast
particles by intestinal epithelial cells has been demonstrated. The route seems to
involve a transcellular step and not paracellular pathway (45,48,170).
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The human colon is host to many commensal bacteria including E.coli and their
cell wall products (LPS) and from this study it appears that LPS may increase the
uptake of luminal microparticles. The significance of this uptake in relation to
possible pathological states requires further studies.
170
CHAPTER 9: GENERAL DISCUSSION
For the first time, particles of chromium have been reported in Crohn's intestine.
In this study, chromium particles were detected by energy dispersive analysis of
X-ray (EDAX) in Crohn's intestine. Chromium is found most commonly as
chromite. Chromite, chromium-iron oxide, occurs naturally as a dark brown or
black mineral. The molecular weight of chromium is 52. Chromium as its
compound may be present in various states: (i) Divalent chromium ((Cr (II)):
chromous chloride and chromous sulphate; (ii) Trivalent chromium (Cr(lll)):
chromic oxide, chromic sulphate and chromic chloride; (III) Hexavalent chromium
(Cr(VI): chromium trioxide, chromates, dichromates and polychromates.
Chromium is widely used as metallic chromium in preparing special steels and
alloys. Also, it is widely used in the glass and ceramic industries, in preparing
paints and as a preservative in the wood industry. The adverse effect of
chromium on health is associated with the valency state and water solubility.
Hexavalent chromium is of most concern. The half-lives of chromium after a
single exposure to rats is 84 days (259). The principal adverse effect of
chromium on exposure is ulceration of the skin and mucous membrane. In
experimental rats exposed to chromium, the metal has been shown to cause
infiltration of alveolar macrophages and interstitial inflammation in lungs and is
considered as immunogenic. There is no similar study in relation to the intestinal
tissues. Thus the effect of chromium in human intestinal tissues is unknown and
studies are required to evaluate the possible role of chromium in the
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pathogenesis of chronic intestinal inflammation. Other than chromium, particles
of aluminium, titanium, and silicon have been identified in IBD tissues. These
particles are non-degradable and exist in their compound forms. Particles of
aluminium, silicon, and titanium have been reported in a previous study. In this
thesis, a second report on inorganic particles has been presented.
The second important observation in this thesis is the experimental evidence of
luminal uptake of polystyrene microparticles by the human intestinal mucosa, and
the increased uptake of microparticles by inflamed human intestinal mucosa in
the presence of lipopolysaccharide. In other work with animal models, it has been
observed that inert microparticles are taken up by intestinal epithelial cells.
However, we did not have any information on whether such inert microparticles
are taken up by human intestinal mucosa. In the present thesis this question has
been investigated in an organ culture model of human intestinal tissues as it is
not permissible to conduct such a study in vivo in humans. Organ culture has
been widely used in respiratory medicine to study the uptake of environmental
microparticles and to understand the pathogenesis of various diseases.
However, studies with organ cultures of gastrointestinal tissues have been limited
to investigating the toxic effects of substances such as gliadin, etc.
In this thesis, for the first time, the uptake of polystyrene latex particles has been
clearly demonstrated in human intestinal tissues in an organ culture model. In
this experimental model, fluorescent polystyrene microparticles were shown to be
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taken into human intestinal tissues in organ culture. The uptake of polystyrene
fluorescent microparticles by intestinal cells in vivo has been demonstrated by
other workers. In the present thesis, fluorescent polystyrene microparticles were
shown to be present in the human colonic epithelium and beneath the epithelium
in the lamina propria by confocal laser scanning microscopy. This finding was
further substantiated by electron microscopy showing polystyrene microparticles
present on the apical side of the human colonic epithelial cells in vesicles.
Polystyrene microparticles were not observed between the epithelial cells
[paracellular]. This finding supports the view that the monodisperse latex
microparticles were endocytosed by the human colonic epithelial cells. Regarding
the mechanism of uptake of microparticles, no coated pits were visible in the
vesicles, and this excludes the possibility of clathrin coated receptor-mediated
endocytosis. Other than receptor-mediated endocytosis, the possibility of
caveolin-mediated and non-coated vesicular uptake can be excluded by the size
of the microparticles (2 pm) used in these experiments. Macropinosomes are
mostly 0.5 - 2 pm but can be up to several microns in size. Therefore the uptake
of the polystyrene microparticles observed in these experiments appears to be by
macropinocytosis. This mode of uptake of microparticles by the intestinal
epithelium has been proposed by other investigators in animal studies in vivo.
In this thesis an organ culture model has been developed to study the uptake of
inert particles by human intestinal mucosa. The observation of the experimental
studies presented demonstrates the endocytic mechanism of luminal uptake of
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particulates by the epithelial cells. This also explains the possibility of uptake of
inorganic luminal particulates such as chromium. However the possible
pathogenic role of chromium in human intestinal tissues needs to be explored.
In the experiments presented in this thesis, human colonic biopsies were shown
to be viable in short-term organ culture for up to 24 hours. Viability of the cultured
tissue was assessed by good morphological preservation of the tissues as
judged by light and electron microscopy. Incorporation of the 3H-thymidine
analogue bromodeoxyuridine in the DNA of the human colonic crypt cells
indicates the synthetic capacity of the tissues in the present organ culture
system. Morphology of the cultured tissues in the present study was well
maintained as examined by light microscopy. This finding has been strengthened
by ultrastructural examination of the cultured tissues by electron microscopy.
Transmission electron microscopic examination of the cultured intestinal tissues
has clearly demonstrated the integrity of the epithelium as indicated by intact
tight junctions, detailed cell structure and organised subcellular structures such
as active mitochondria, endoplasmic reticulum and secondary lysosomes. These
findings indicate the stability of the present organ culture system and its
suitability for studies related to luminal uptake of particulates.
Organ culture of human intestinal tissues offers several advantages. In this
model it is possible to study the uptake of substances such as polystyrene
microparticles or chromium that cannot be conducted in vivo. It provides a model
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in which both epithelial and interstitial tissues are present in their anatomical
arrangement. This is clearly an advantage over cell culture studies. The
microparticles have been taken up by the epithelial cells and subsequently into
the interstitium over the time of the study, mimicking the process in vivo.
However, this model has some limitations for uptake studies and these limitations
must be kept in mind. In vitro, the process of uptake may be slower compared to
the in vivo situation as only small amount of tissue is available for the
experimentation. Regarding dosing of microparticles and size, it is difficult to
predict what dose and size of microparticles really reflects the in vivo situation.
This in vitro experimentation is in a static condition whereas in vivo the uptake of
microparticles occurs in a dynamic state. However, in the present experiments
biopsies were collected from the colon, where the dynamic state is less marked
compared to that of the proximal intestine. Therefore, any environmental particles
present in the lumen will remain for a longer period in this segment of the
intestine. From this point of view, this model for uptake studies is probably not
very much different from the real situation. The work presented in this thesis
might be the beginning of further studies on uptake of microparticle in cultured
intestinal mucosa. This model can be extended to study the effect of dose of
lipopolysaccharide on uptake of the particles in tissues from different segments
of the intestine. It is possible that uptake of polystyrene microparticles would be
different if a higher dose of LPS had been used in the experiments presented in
this thesis (chapter 7).
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The direct observation of microparticles within the epithelium and in the lamina
propria is one of the major strengths of this model in interpreting the results.
Even then, the results may not be reflective of events that occur in the intestinal
lumen where different factors are operating their role.
Most of the published literature suggests that M cells in follicle-associated
epithelium are the portals of entry for bacteria, viruses and microparticles. It has
now emerged that bacteria and microparticles (2-p.m) are transcytosed by the
intestinal epithelial cells. Results of in vitro experiments described in this thesis
confirm this observation for human colonic epithelial cells, particularly in IBD.
Beneath the epithelium, polystyrene microparticles were observed in
macrophages. This finding correlates well with the identification of
immunostained macrophages containing inorganic microparticles in the lamina
propria in the resected intestine of IBD patients presented in this thesis.
In this thesis, macrophages containing inorganic particles have been
demonstrated in human intestinal mucosa. Macrophages in the intestine have
been reported to be increased in inflammatory bowel disease. However, there
are no data on inorganic microparticle-laden macrophages in human intestine.
For the first time, data on inorganic-microparticle-laden macrophages have been
presented in this thesis. The results of the quantitative image analysis of
inorganic microparticle-laden macrophages in the human intestinal mucosa
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indicate that numbers of inorganic microparticle-laden macrophages were
significantly greater in intestinal tissues of Crohn's patients compared to controls.
Also, it has been demonstrated that area occupied by macrophages in the
inflamed intestine is significantly increased in inflammatory bowel disease. This is
also the first reporting of the application of an image analysis method to study
macrophages in human intestine.
Macrophages in the inflamed intestine are believed to be secreting
proinflammatory cytokines e.g., TNF-a which is probably the key event in
perpetuation /activation of inflammatory bowel disease. Several studies have
demonstrated an increase in the macrophage population in IBD and the increase
in microparticle-laden macrophages observed in the present study suggests that
microparticles present in the lumen alone or in combination with other factors
such as LPS may play a role in the activation of intestinal macrophages. It is
therefore necessary to investigate the role of microparticles such as chromium in
activating macrophages, which can be studied by in vitro experiments either by
harvesting intestinal macrophages or by studies with a macrophage cell line. We
do not have any information on the fate of macrophages that have phagocytosed
inorganic microparticles whether ingested microparticles cause any damage or
dysfunction of these cells. This also merits investigation to understand the
duration of the functional capacity of the macrophages involved.
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In conclusion, attempts have been made in this thesis to answer a few key
questions on the possibility of luminal uptake of microparticles by human
intestinal epithelium. The apparently important findings are:
1. Uptake of non-degradable microparticles does occur in human intestine.
Any pre-existing pathology such as inflammation increases this process of
uptake.
2. Uptake of microparticles is an endocytic process, more specifically
macropinocytosis.
3. Lipopolysaccharide further augments the uptake of microparticles in IBD.
4. Inorganic microparticle-laden macrophages are significantly increased in
Crohn's intestine.
Prospective studies on the possible role of non-degradable microparticles in the
pathogenesis of IBD are merited and may yield useful information. It is possible
to record the numbers of microparticles in biopsy specimens taken from newly
diagnosed Crohn's patients and to correlate these findings with the course of the
disease.
In parallel, similar studies are required in a population not exposed to diets with
food additives, which are likely the main sources of non-degradable
microparticles. A country with an agriculture-based economy is probably the right
place to conduct such a study.
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In this thesis, an organ culture model has been successfully applied to study
uptake of microparticles by human intestinal tissues. This model may be applied
to study uptake of similar other particles across human intestinal epithelium
which is not feasible in vivo. Any study on definitive uptake of prion particles
across human intestinal epithelium is lacking. This experimental model may be
applied to study uptake of prion particles across human intestinal epithelium and
may be extended to study the internalisation process of infectious prion proteins.
The technical work involved in these studies is time consuming. Organ culture,
processing of tissues, confocal and electron microscopy, X-ray microanalysis and
other related work such as image analysis are labour-intensive, and demanding
processes. If time permitted, it might be rewarding to study uptake of
microparticles in organ culture of human intestinal tissues at different
concentrations of lipopolysaccharide and to evaluate whether an increased dose
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